HP INC, 10-Q filed on 5/29/2025
Quarterly Report
v3.25.1
Cover Page - shares
 6 Months Ended
Apr. 30, 2025
May 22, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Apr. 30, 2025  
Document Transition Report false  
Entity File Number 1-4423  
Entity Registrant Name HP INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 94-1081436  
Entity Address, Address Line One 1501 Page Mill Road  
Entity Address, City or Town Palo Alto,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94304  
City Area Code 650  
Local Phone Number 857-1501  
Title of 12(b) Security Common stock, par value $0.01 per share  
Trading Symbol HPQ  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   939,272,878
Entity Central Index Key 0000047217  
Amendment Flag false  
Current Fiscal Year End Date --10-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
v3.25.1
Consolidated Condensed Statements of Earnings (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Net revenue:        
Total net revenue $ 13,220 $ 12,800 $ 26,724 $ 25,985
Cost of net revenue:        
Total cost of net revenue 10,481 9,777 21,145 20,074
Gross profit 2,739 3,023 5,579 5,911
Research and development 401 436 798 835
Selling, general and administrative 1,480 1,462 2,939 2,845
Restructuring and other charges 122 71 192 134
Acquisition and divestiture charges 17 22 23 49
Amortization of intangible assets 65 80 128 161
Total operating expenses 2,085 2,071 4,080 4,024
Earnings from operations 654 952 1,499 1,887
Interest and other, net (148) (155) (289) (297)
Earnings before taxes 506 797 1,210 1,590
Provision for taxes (100) (190) (239) (361)
Net earnings $ 406 $ 607 $ 971 $ 1,229
Net earnings per share:        
Basic (usd per share) $ 0.43 $ 0.62 $ 1.02 $ 1.24
Diluted (usd per share) $ 0.42 $ 0.61 $ 1.02 $ 1.23
Weighted-average shares used to compute net earnings per share:        
Basic (in shares) 950 984 949 990
Diluted (in shares) 956 990 956 996
Products        
Net revenue:        
Total net revenue $ 12,423 $ 12,043 $ 25,118 $ 24,462
Cost of net revenue:        
Total cost of net revenue 10,007 9,324 20,201 19,195
Services        
Net revenue:        
Total net revenue 797 757 1,606 1,523
Cost of net revenue:        
Total cost of net revenue $ 474 $ 453 $ 944 $ 879
v3.25.1
Consolidated Condensed Statements of Comprehensive (Loss) Income (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Statement of Comprehensive Income [Abstract]        
Net earnings $ 406 $ 607 $ 971 $ 1,229
Change in unrealized components of available-for-sale debt securities:        
Unrealized gains arising during the period 2 0 6 4
Change in unrealized components of cash flow hedges:        
Unrealized (losses) gains arising during the period (692) 151 (360) (11)
Gains reclassified into earnings (148) (5) (191) (164)
Change in unrealized components of cash flow hedges (840) 146 (551) (175)
Change in unrealized components of defined benefit plans:        
Unrealized (losses) gains arising during the period (2) 23 (1) 13
Amortization of actuarial loss and prior service benefit 5 2 10 4
Curtailments, settlements and other 1 1 0 1
Change in unrealized components of defined benefit plans 4 26 9 18
Change in cumulative translation adjustment 30 (6) 17 14
Other comprehensive (loss) income before taxes (804) 166 (519) (139)
Benefit from (provision for) taxes 165 (40) 110 30
Other comprehensive (loss) income, net of taxes (639) 126 (409) (109)
Comprehensive income (loss) $ (233) $ 733 $ 562 $ 1,120
v3.25.1
Consolidated Condensed Balance Sheets (Unaudited) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Current assets:    
Cash, cash equivalents and restricted cash $ 2,730 $ 3,253
Accounts receivable, net of allowance for credit losses of $85 and $83, as of April 30, 2025 and October 31, 2024, respectively 4,336 5,117
Inventory 8,175 7,720
Other current assets 4,217 4,670
Total current assets 19,458 20,760
Property, plant and equipment, net 2,951 2,914
Goodwill 8,713 8,627
Other non-current assets 7,677 7,608
Total assets 38,799 39,909
Current liabilities:    
Notes payable and short-term borrowings 1,446 1,406
Accounts payable 15,195 16,903
Other current liabilities 9,915 10,378
Total current liabilities 26,556 28,687
Long-term debt 9,291 8,263
Other non-current liabilities 4,228 4,282
Stockholders’ deficit:    
Preferred stock, $0.01 par value (300 shares authorized; none issued) 0 0
Common stock, $0.01 par value (9,600 shares authorized; 942 and 939 shares issued and outstanding as of April 30, 2025 and October 31, 2024, respectively) 9 9
Additional paid-in capital 1,999 1,778
Accumulated deficit (2,441) (2,676)
Accumulated other comprehensive loss (843) (434)
Total stockholders’ deficit (1,276) (1,323)
Total liabilities and stockholders’ deficit $ 38,799 $ 39,909
v3.25.1
Consolidated Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Statement of Financial Position [Abstract]    
Accounts receivable, net of allowance for credit losses $ 85 $ 83
Preferred stock, par value (usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 300,000,000 300,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 9,600,000,000 9,600,000,000
Common stock, shares issued (in shares) 942,000,000 939,000,000
Common stock, shares outstanding (in shares) 942,000,000 939,000,000
v3.25.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Cash flows from operating activities:    
Net earnings $ 971 $ 1,229
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 402 414
Stock-based compensation expense 332 271
Restructuring and other charges 192 134
Deferred taxes on earnings (83) 0
Other, net 72 (13)
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 851 (106)
Inventory (472) (678)
Accounts payable (1,699) 360
Net investment in leases related to integrated financing (48) (81)
Taxes on earnings (121) (128)
Restructuring and other (149) (144)
Other assets and liabilities 164 (556)
Net cash provided by operating activities 412 702
Cash flows from investing activities:    
Investment in property, plant, equipment and purchased intangible (485) (277)
Purchases of available-for-sale securities and other investments (6) 0
Maturities and sales of available-for-sale securities and other investments 14 0
Collateral posted for derivative instruments (540) 0
Payment made in connection with business acquisitions, net of cash acquired (116) 0
Net cash used in investing activities (1,133) (277)
Cash flows from financing activities:    
Proceeds from debt, net of issuance costs 1,158 186
Payment of debt and associated costs (102) (102)
Stock-based award activities and others (118) (80)
Repurchase of common stock (200) (600)
Cash dividends paid (546) (544)
Settlement of cash flow hedges 6 0
Net cash provided by (used in) financing activities 198 (1,140)
Decrease in cash, cash equivalents and restricted cash (523) (715)
Cash, cash equivalents and restricted cash at beginning of period 3,253 3,232
Cash, cash equivalents and restricted cash at end of period $ 2,730 $ 2,517
v3.25.1
Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2023   988,782      
Balance at the beginning of period at Oct. 31, 2023 $ (1,069) $ 10 $ 1,505 $ (2,361) $ (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 622     622  
Other comprehensive income (loss), net of taxes (235)       (235)
Comprehensive income (loss) 387        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,677      
Issuance of common stock in connection with employee stock plans and other (76)   (76)    
Repurchases of common stock (in shares)   (17,062)      
Repurchases of common stock (Note 10) (514)   (27) (487)  
Cash dividends (545)     (545)  
Stock-based compensation expense 177   177    
Balance (in shares) at Jan. 31, 2024   980,397      
Balance at the end of period at Jan. 31, 2024 (1,640) $ 10 1,579 (2,771) (458)
Balance (in shares) at Oct. 31, 2023   988,782      
Balance at the beginning of period at Oct. 31, 2023 (1,069) $ 10 1,505 (2,361) (223)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,229        
Other comprehensive income (loss), net of taxes (109)        
Comprehensive income (loss) $ 1,120        
Repurchases of common stock (in shares) (20,500)        
Balance (in shares) at Apr. 30, 2024   977,507      
Balance at the end of period at Apr. 30, 2024 $ (916) $ 10 1,663 (2,257) (332)
Balance (in shares) at Jan. 31, 2024   980,397      
Balance at the beginning of period at Jan. 31, 2024 (1,640) $ 10 1,579 (2,771) (458)
Increase (Decrease) in Stockholders' Equity          
Net earnings 607     607  
Other comprehensive income (loss), net of taxes 126       126
Comprehensive income (loss) 733        
Issuance of common stock in connection with employee stock plans and other (in shares)   584      
Issuance of common stock in connection with employee stock plans and other $ (4)   (4)    
Repurchases of common stock (in shares) (3,500) (3,474)      
Repurchases of common stock (Note 10) $ (99)   (6) (93)  
Stock-based compensation expense 94   94    
Balance (in shares) at Apr. 30, 2024   977,507      
Balance at the end of period at Apr. 30, 2024 $ (916) $ 10 1,663 (2,257) (332)
Balance (in shares) at Oct. 31, 2024 939,000 938,989      
Balance at the beginning of period at Oct. 31, 2024 $ (1,323) $ 9 1,778 (2,676) (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 565     565  
Other comprehensive income (loss), net of taxes 230       230
Comprehensive income (loss) 795        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,405      
Issuance of common stock in connection with employee stock plans and other (92)   (92)    
Repurchases of common stock (in shares)   (2,734)      
Repurchases of common stock (Note 10) (97)   (4) (93)  
Cash dividends (547)     (547)  
Stock-based compensation expense 192   192    
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the end of period at Jan. 31, 2025 $ (1,072) $ 9 1,874 (2,751) (204)
Balance (in shares) at Oct. 31, 2024 939,000 938,989      
Balance at the beginning of period at Oct. 31, 2024 $ (1,323) $ 9 1,778 (2,676) (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 971        
Other comprehensive income (loss), net of taxes (409)        
Comprehensive income (loss) $ 562        
Repurchases of common stock (in shares) (5,800)        
Balance (in shares) at Apr. 30, 2025 942,000 942,209      
Balance at the end of period at Apr. 30, 2025 $ (1,276) $ 9 1,999 (2,441) (843)
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the beginning of period at Jan. 31, 2025 (1,072) $ 9 1,874 (2,751) (204)
Increase (Decrease) in Stockholders' Equity          
Net earnings 406     406  
Other comprehensive income (loss), net of taxes (639)       (639)
Comprehensive income (loss) (233)        
Issuance of common stock in connection with employee stock plans and other (in shares)   667      
Issuance of common stock in connection with employee stock plans and other $ (9)   (9)    
Repurchases of common stock (in shares) (3,100) (3,118)      
Repurchases of common stock (Note 10) $ (103)   (6) (97)  
Cash dividends 1     1  
Stock-based compensation expense $ 140   140    
Balance (in shares) at Apr. 30, 2025 942,000 942,209      
Balance at the end of period at Apr. 30, 2025 $ (1,276) $ 9 $ 1,999 $ (2,441) $ (843)
v3.25.1
Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Statement of Stockholders' Equity [Abstract]    
Cash dividends per share (usd per share) $ 0.58 $ 0.55
v3.25.1
Basis of Presentation
 6 Months Ended
Apr. 30, 2025
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation
Basis of Presentation
The accompanying Consolidated Condensed Financial Statements of HP and its wholly owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2024 in HP’s Annual Report on Form 10-K, filed on December 13, 2024. The Consolidated Condensed Balance Sheet for October 31, 2024 was derived from audited financial statements.
Principles of Consolidation
The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Adopted Accounting Pronouncements
In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on rollforward information which will be adopted in its fiscal year 2025 Form 10-K, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.
Recently Issued Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued guidance that requires disaggregation of specific expense categories in disclosures within the footnotes to the financial statements on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2028 and all interim periods thereafter on a prospective basis. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
v3.25.1
Segment Information
 6 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
HP’s operations are organized into three reportable segments: Personal Systems, Printing, and Corporate Investments.
Personal Systems offers desktops, notebooks, and workstations (including HP’s portfolio of AI PCs and workstations), thin clients, retail point-of-sale (“POS”) systems, displays, hybrid systems, software, solutions including endpoint security and services. Personal Systems includes support and deployment, configurations and extended warranty services and maintains multi-operating system and multi-architecture strategies using Microsoft Windows and Google Chrome operating systems, and predominantly using processors from Intel, AMD, and NVIDIA.
Personal Systems groups its global business capabilities into the following business units when reporting business performance:
•Commercial PS consists of endpoint computing devices and hybrid systems, for use by enterprise, public sector (which includes education), and small- and medium-sized business (“SMB”) customers. These devices include HP’s Pro and Elite commercial PC portfolio, HP’s Z line of workstations, thin clients, retail POS systems, and HP’s Dragonfly and Chromebook PCs. HP offers a range of secure services and solutions to commercial customers to help them manage the lifecycle of their PCs and mobility installed base.
•    Consumer PS consists of devices, accessories and services which are optimized for consumer usage, focusing on gaming, learning and working remotely, consuming multi-media for entertainment, managing personal life activities, sharing information and staying connected, informed, and secure. These devices include HP’s new Omni consumer PC portfolio, the Omen and Victus gaming lines, and HP’s Spectre, Envy, Pavilion and Chromebook PCs.
Printing provides consumer and commercial printer hardware, supplies, services and solutions. Printing is also focused on Graphics and 3D Printing and Personalization in the commercial and industrial markets. HP’s global business capabilities within Printing are described below:
•Office Printing Solutions delivers HP’s security enhanced office printers, supplies, services, and solutions to SMBs, public sector and large enterprises. It also includes Original Equipment Manufacturer (“OEM”) hardware and solutions.
•Home Printing Solutions delivers innovative and security enhanced printing products, supplies, services and solutions for the home, home business and micro business customers utilizing both HP’s Ink and Laser technologies.
•Graphics Solutions delivers large-format, commercial and industrial solutions and supplies to print service providers and packaging converters through a wide portfolio of printers and presses.
•3D Printing & Personalization offers a portfolio of additive manufacturing solutions and supplies to help customers succeed in their additive and digital manufacturing journey. HP offers complete solutions in collaboration with an ecosystem of partners.
Printing groups its global business capabilities into the following business units when reporting business performance:
•Commercial Printing consists of office printing solutions, graphics solutions and 3D printing and personalization, excluding supplies;
•Consumer Printing consists of home printing solutions, excluding supplies; and
•Supplies comprises a set of highly innovative consumable products, ranging from ink and laser cartridges to media, industrial graphics supplies and 3D printing and personalization supplies, for recurring use in consumer and commercial hardware.
Corporate Investments includes certain business incubation and investment projects.
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges, amortization of intangible assets, and certain litigation charges.
Segment operating results and the reconciliation to HP consolidated results were as follows:
 Three months ended April 30Six months ended April 30
 2025202420252024
In millions
Net revenue:
Commercial PS$6,786 $6,242 $13,431 $12,287 
Consumer PS2,238 2,184 4,817 4,948 
Personal Systems9,024 8,426 18,248 17,235 
Supplies2,725 2,864 5,551 5,727 
Commercial Printing1,167 1,205 2,311 2,432 
Consumer Printing289 299 588 584 
Printing4,181 4,368 8,450 8,743 
Corporate Investments16 5 27 7 
Total segment net revenue13,221 12,799 26,725 25,985 
Other(1)1 (1)— 
Total net revenue$13,220 $12,800 $26,724 $25,985 
  
Earnings before taxes:
Personal Systems$409 $508 $916 $1,045 
Printing814 829 1,624 1,701 
Corporate Investments(37)(30)(64)(67)
Total segment earnings from operations1,186 1,307 2,476 2,679 
Corporate and unallocated costs and other(85)(88)(199)(177)
Stock-based compensation expense(140)(94)(332)(271)
Restructuring and other charges(122)(71)(192)(134)
Acquisition and divestiture charges(17)(22)(23)(49)
Amortization of intangible assets(65)(80)(128)(161)
Certain litigation charges
(103)— (103)— 
Interest and other, net(148)(155)(289)(297)
Total earnings before taxes$506 $797 $1,210 $1,590 
v3.25.1
Restructuring and Other Charges
 6 Months Ended
Apr. 30, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Other Charges Restructuring and Other Charges
Summary of Restructuring Plans
HP’s restructuring activities summarized by plan were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans(1)
Total
In millions
Accrued balance as of October 31, 2024$120 $11 $7 $138 
Charges141 20 — 161 
Cash payments(110)(6)(2)(118)
Non-cash and other adjustments1 (16)— (15)
Accrued balance as of April 30, 2025$152 $9 $5 $166 
Total costs incurred to date as of April 30, 2025$748 $77 $878 $1,703 
Reflected in the Consolidated Condensed Balance Sheets
Other current liabilities$152 $3 $5 $160 
Other non-current liabilities$— $6 $— $6 
Accrued balance as of October 31, 2023$88 $18 $2 $108 
Charges93 6 3 102 
Cash payments(100)(9)(3)(112)
Non-cash and other adjustments2 (2)(2)(2)
Accrued balance as of April 30, 2024$83 $13 $— $96 
HP’s restructuring charges for the three months ended April 30, 2025 summarized by the plans outlined below were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans (1)
Total
In millions
For the three months ended April 30, 2025$97 $8 $— $105 
(1)     Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.
Fiscal 2023 Plan
On November 18, 2022, HP’s Board of Directors approved the Future Ready Plan (the “Fiscal 2023 Plan”) intended to enable digital transformation, portfolio optimization and operational efficiency which HP expects will be implemented through fiscal 2025. HP estimates that it will incur pre-tax charges of approximately $1.0 billion of which approximately $0.7 billion primarily in labor costs related to workforce reductions and the remaining costs will relate to non-labor actions and other charges.
On February 27, 2025, HP approved an amendment to the Fiscal 2023 Plan increasing its expected gross workforce reductions of 7,000 employees by approximately 1,000 to 2,000 employees. The changes to the workforce will vary by country, based on local legal requirements and consultations with employee works councils and other employee representatives, as appropriate. The Company anticipates incurring an additional $150 million in restructuring and other charges primarily related to labor costs in connection with the plan amendment.
Other Charges
Other charges include non-recurring costs, including those as a result of information technology rationalization efforts and transformation program management costs, and are distinct from ongoing operational costs. These costs primarily relate to third-party professional services and other non-recurring costs. For the three and six months ended April 30, 2025, HP incurred $17 million and $31 million of other charges, respectively. For the three and six months ended April 30, 2024, HP incurred $17 million and $32 million of other charges, respectively.
v3.25.1
Retirement and Post-Retirement Benefit Plans
 6 Months Ended
Apr. 30, 2025
Retirement Benefits [Abstract]  
Retirement and Post-Retirement Benefit Plans Retirement and Post-Retirement Benefit Plans
The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:
 Three months ended April 30
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost-Retirement Benefit Plans
 202520242025202420252024
 In millions
Service cost$— $— $10 $9 $— $— 
Interest cost53 57 10 11 3 4 
Expected return on plan assets(62)(62)(13)(13)(3)(4)
Amortization and deferrals:      
Actuarial loss (gain)8 7 2 — (5)(4)
Prior service cost (credit)— — 1 1 (1)(2)
Net periodic benefit (credit) cost(1)2 10 8 (6)(6)
Settlement loss— — 1 1 — — 
Total periodic benefit (credit) cost$(1)$2 $11 $9 $(6)$(6)
 Six months ended April 30
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost-Retirement Benefit Plans
 202520242025202420252024
 In millions
Service cost$— $— $19 $18 $— $— 
Interest cost106 114 20 23 7 8 
Expected return on plan assets(121)(123)(27)(26)(7)(8)
Amortization and deferrals:
Actuarial loss (gain)15 14 4 — (9)(8)
Prior service cost (credit)— — 3 3 (3)(5)
Net periodic benefit cost (credit)$— $5 $19 $18 $(12)$(13)
Settlement loss — — 1 1 — — 
Total periodic benefit cost (credit)$— $5 $20 $19 $(12)$(13)
Employer Contributions and Funding Policy
HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.
During the six months ended April 30, 2025, HP contributed $21 million to its non-U.S. pension plans, $13 million to cover benefit payments to U.S. non-qualified plan participants and $4 million to cover benefit claims under HP’s post-retirement benefit plans.
v3.25.1
Taxes on Earnings
 6 Months Ended
Apr. 30, 2025
Income Tax Disclosure [Abstract]  
Taxes on Earnings Taxes on Earnings
Provision for Taxes
HP’s effective tax rate was 19.8% and 23.8% for the three months ended April 30, 2025 and 2024, respectively, and 19.8% and 22.7% for the six months ended April 30, 2025 and 2024, respectively.
During the three and six months ended April 30, 2025, HP recorded $40 million and $34 million of net income tax benefits, respectively, related to discrete items in the provision for taxes. The three and six months ended April 30, 2025 included benefits of $19 million related to litigation charges and $24 million and $38 million related to restructuring charges, respectively. For the six months ended April 30, 2025, these benefits were partially offset by $15 million of uncertain tax position charges and $17 million related to changes in tax rates. In addition to the discrete items mentioned above, HP recorded excess tax benefits of $15 million associated with stock options, restricted stock units and performance-adjusted restricted stock units for the six months ended April 30, 2025.
Uncertain Tax Positions
As of April 30, 2025, the amount of gross unrecognized tax benefits was $1.2 billion, of which up to $886 million would affect HP’s effective tax rate if realized. Total gross unrecognized tax benefits increased by $15 million for the six months ended April 30, 2025. HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings. As of April 30, 2025 and 2024, HP had accrued $157 million and $119 million, respectively, for interest and penalties.
HP engages in continuous discussions and negotiations with taxing authorities regarding tax matters in various jurisdictions. HP expects complete resolution of certain tax years with various tax authorities within the next 12 months. HP believes it is reasonably possible that its existing gross unrecognized tax benefits may be reduced by $182 million within the next 12 months, affecting HP’s effective tax rate if realized.
HP is subject to income tax in the United States and approximately 61 other countries and is subject to routine corporate income tax audits in many of these jurisdictions. In addition, HP is subject to numerous ongoing audits by federal, state and foreign tax authorities. The Internal Revenue Service (“IRS”) is conducting an audit of HP’s 2018 and 2019 income tax returns.
v3.25.1
Supplementary Financial Information
 6 Months Ended
Apr. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplementary Financial Information Supplementary Financial Information
Cash, Cash Equivalents and Restricted Cash
 As of
 April 30, 2025October 31, 2024
 In millions
Cash and cash equivalents$2,697 $3,238 
Restricted cash(1)
33 15 
$2,730 $3,253 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Accounts Receivable
The allowance for credit losses related to accounts receivable and changes were as follows:
 Six months ended April 30, 2025
 In millions
Balance at beginning of period$83 
Current-period allowance for credit losses6 
Deductions, net of recoveries(4)
Balance at end of period$85 
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of April 30, 2025 and October 31, 2024 were not material.
The following is a summary of the activity under these arrangements:
Three months ended April 30Six months ended April 30
 2025 20242025 2024
 In millions
Balance at beginning of period(1)
$133 $212 $284 $141 
Trade receivables sold3,125 2,846 6,174 6,145 
Cash receipts(3,056)(2,873)(6,247)(6,106)
Foreign currency and other15 (4)6 1 
Balance at end of period(1)
$217 $181 $217 $181 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.
Inventory
 As of
 April 30, 2025October 31, 2024
 In millions
Finished goods$4,469 $4,338 
Purchased parts and fabricated assemblies3,706 3,382 
$8,175 $7,720 

Other Current Assets
 As of
 April 30, 2025October 31, 2024
 In millions
Supplier and other receivables$1,404 $2,180 
Prepaid and other current assets1,840 1,462 
Value-added taxes receivable973 1,028 
$4,217 $4,670 

Property, Plant and Equipment, Net
 As of
 April 30, 2025October 31, 2024
 In millions
Land, buildings and leasehold improvements$2,560 $2,527 
Machinery and equipment, including equipment held for lease5,746 5,465 
8,306 7,992 
Accumulated depreciation(5,355)(5,078)
$2,951 $2,914 

Other Non-Current Assets
 As of
 April 30, 2025October 31, 2024
 In millions
Deferred tax assets$3,513 $3,311 
Intangible assets1,228 1,319 
Right-of-use assets1,104 1,165 
Prepaid pension and post-retirement benefit assets389 362 
Deposits and prepaid305 322 
Other1,138 1,129 
$7,677 $7,608 
Other Current Liabilities
 As of
 April 30, 2025October 31, 2024
 In millions
Sales and marketing programs$2,826 $3,060 
Deferred revenue1,495 1,446 
Other accrued taxes1,141 1,233 
Employee compensation and benefits743 970 
Warranty429 486 
Operating lease liabilities413 443 
Tax liability263 291 
Other2,605 2,449 
$9,915 $10,378 

Other Non-Current Liabilities
 As of
 April 30, 2025October 31, 2024
In millions
Deferred revenue$1,544 $1,487 
Operating lease liabilities766 787 
Tax liability755 839 
Pension, post-retirement, and post-employment liabilities597 607 
Deferred tax liability29 31 
Other537 531 
$4,228 $4,282 

Interest and Other, Net
 Three months ended April 30Six months ended April 30
 202520242025 2024
 In millions
Interest expense on borrowings$(114)$(122)$(218)$(238)
Factoring costs(32)(40)(69)(79)
Non-operating retirement-related credits4 2 10 6 
Other, net(6)5 (12)14 
$(148)$(155)$(289)$(297)
Net Revenue by Region
Three months ended April 30Six months ended April 30
 202520242025 2024
 In millions
Americas$5,793 $5,591 $11,312 $10,999 
Europe, Middle East and Africa
4,393 4,373 9,147 9,041 
Asia-Pacific and Japan3,034 2,836 6,265 5,945 
Total net revenue$13,220 $12,800 $26,724 $25,985 
Value of Remaining Performance Obligations
As of April 30, 2025, the estimated value of transaction price allocated to remaining performance obligations was $4.0 billion. HP expects to recognize approximately $1.8 billion of the unearned amount in next 12 months and $2.2 billion thereafter.
HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if:
•the contract has an original expected duration of one year or less; or
•the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or
•the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation.
The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency.
Contract Liabilities
As of April 30, 2025 and October 31, 2024, HP’s contract liabilities balances were $3.0 billion and $2.9 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Consolidated Condensed Balance Sheets.
The increase in the contract liabilities balance for the six months ended April 30, 2025, was primarily driven by sales of fixed-price support and maintenance services, partially offset by $0.9 billion of revenue recognized that was included in the contract liabilities balance as of October 31, 2024.
Supplier Finance Programs
HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under these programs, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs have no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. For certain programs, HP pays a monthly service fee to a third-party administrator that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of April 30, 2025 and October 31, 2024, HP had $7.7 billion and $7.8 billion respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs. Of the amounts confirmed as valid under the program and outstanding, the amounts owed to participating financial institutions were $0.6 billion and $0.9 billion as of April 30, 2025 and October 31, 2024, respectively. These obligations are included within the Accounts payable line item of HP’s Consolidated Condensed Balance Sheets.
v3.25.1
Fair Value
 6 Months Ended
Apr. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
    The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
 As of April 30, 2025As of October 31, 2024
 Fair Value Measured UsingFair Value Measured Using
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
 In millions
Assets:        
Cash Equivalents:        
Time deposits
$— $1,237 $— $1,237 $— $1,012 $— $1,012 
Government debt(1)
721 — — 721 1,332 — — 1,332 
Available-for-Sale Investments:
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds(2)
53 123 — 176 54 130 — 184 
Derivative Instruments:    
Interest rate contracts— — — — — 4 — 4 
Foreign currency contracts— 63 — 63 — 225 — 225 
Other derivatives— 3 — 3 — — — — 
Total assets$774 $1,429 $— $2,203 $1,386 $1,374 $— $2,760 
Liabilities:        
Derivative Instruments:        
Interest rate contracts$— $6 $— $6 $— $22 $— $22 
Foreign currency contracts— 565 — 565 — 158 — 158 
Other derivatives— — — — — 2 — 2 
Total liabilities$— $571 $— $571 $— $182 $— $182 
(1)    Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.
(2)    As of April 30, 2025 and October 31, 2024, $69 million and $78 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
Valuation Techniques
Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $10.4 billion as compared to its carrying amount of $10.7 billion as of April 30, 2025. The fair value of HP’s short- and long-term debt was $9.4 billion as compared to its carrying value of $9.7 billion as of October 31, 2024. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.
v3.25.1
Financial Instruments
 6 Months Ended
Apr. 30, 2025
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash Equivalents and Available-for-Sale Investments
 As of April 30, 2025As of October 31, 2024
 CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
 In millions
Cash Equivalents:        
Time deposits
$1,237 $— $— $1,237 $1,012 $— $— $1,012 
Government debt721 — — 721 1,332 — — 1,332 
Total cash equivalents1,958 — — 1,958 2,344 — — 2,344 
Available-for-Sale Investments:     
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds(1)
112 64 — 176 115 69 — 184 
Total available-for-sale investments115 64 — 179 118 69 — 187 
Total cash equivalents and available-for-sale investments$2,073 $64 $— $2,137 $2,462 $69 $— $2,531 
(1)    As of April 30, 2025 and October 31, 2024, $69 million and $78 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of April 30, 2025 and October 31, 2024, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of April 30, 2025
 Amortized CostFair Value
 In millions
Due in one year$17 $17 
Due in one to five years55 55 
$72 $72 
Non-marketable equity securities in privately held companies are included in Other current and non-current assets in the Consolidated Condensed Balance Sheets. These amounted to $100 million and $107 million as of April 30, 2025 and October 31, 2024, respectively.
HP determines credit losses on cash equivalents and available-for-sale debt securities at the individual security level. All instruments are considered investment grade. No credit-related or noncredit-related impairment losses were recorded for the three and six months ended April 30, 2025.
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $506 million and $59 million as of April 30, 2025 and as of October 31, 2024, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of April 30, 2025 and October 31, 2024.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted products net revenue, cost of products net revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements, contractual pricing and/or business unit specific exposures may extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
In April 2025, a series of forward starting swaps and a treasury rate lock totaling $825 million notional amount were settled upon the issuance of the senior unsecured notes resulting in a net gain of $6 million recognized in Accumulated other comprehensive loss. The gain will be reclassified to Interest and other, net over the life of the related debt.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
During the three and six months ended April 30, 2025 and 2024, no portion of the hedging instruments’ gain or loss was excluded from the assessment of effectiveness for fair value and cash flow hedges.
Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:
 As of April 30, 2025As of October 31, 2024
 Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
 In millions
Derivatives designated as hedging instruments     
Fair value hedges:     
Interest rate contracts$750 $— $— $6 $— $750 $— $— $11 $10 
Cash flow hedges:
Foreign currency contracts15,443 40 9 456 91 14,563 169 36 117 34 
Interest rate contracts— — — — — 500 — 4 — 1 
Total derivatives designated as hedging instruments16,193 40 9 462 91 15,813 169 40 128 45 
Derivatives not designated as hedging instruments    
Foreign currency contracts4,571 14 — 18 — 4,284 20 — 7 — 
Other derivatives146 3 — — — 156 — — 2 — 
Total derivatives not designated as hedging instruments4,717 17 — 18 — 4,440 20 — 9 — 
Total derivatives$20,910 $57 $9 $480 $91 $20,253 $189 $40 $137 $45 
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of April 30, 2025 and October 31, 2024, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of April 30, 2025       
Derivative assets$66 $— $66 $59 $— (1)$7 
Derivative liabilities$571 $— $571 $59 $535 (2)$(23)
As of October 31, 2024       
Derivative assets$229 $— $229 $113 $88 (1)$28 
Derivative liabilities$182 $— $182 $113 $61 (2)$8 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Effect of Derivative Instruments in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
Derivative InstrumentHedged ItemLocationYearTotal amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recordedGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended April 30
Interest rate contractFixed-rate debtInterest and other, net2025$(148)$8 $(8)
2024$(155)$— $— 
Six months ended April 30
Interest rate contractFixed-rate debtInterest and other, net2025$(289)$15 $(15)
2024$(297)$15 $(15)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended April 30Six months ended April 30
2025202420252024
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$(687)$151 $(363)$(11)
Interest rate contracts(5)— 3 — 
Total$(692)$151 $(360)$(11)
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
Gain/(loss) reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended April 30Six months ended April 30
2025202420252024
In millions
Products net revenue$167 $39 $234 $238 
Cost of products net revenue(23)(36)(50)(76)
Operating expenses1 (1)1 (4)
Interest and other, net3 3 6 6 
Total$148 $5 $191 $164 
As of April 30, 2025, HP expects to reclassify an estimated accumulated other comprehensive loss of $351 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in Accumulated other comprehensive (loss) income based on the change of market rate, and therefore could have different impacts on earnings.
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:
Gain/(loss) recognized in earnings on derivative instrument
 Three months ended April 30Six months ended April 30
 Location2025202420252024
  In millions
Foreign currency contractsInterest and other, net$(11)$6 $(14)$7 
Other derivativesInterest and other, net1 (6)5 (2)
Total $(10)$— $(9)$5 
v3.25.1
Borrowings
 6 Months Ended
Apr. 30, 2025
Debt Disclosure [Abstract]  
Borrowings Borrowings
Notes Payable and Short-Term Borrowings
 As of April 30, 2025As of October 31, 2024
 Amount
Outstanding		Weighted-Average
Interest Rate		Amount
Outstanding		Weighted-Average
Interest Rate
 In millions
Current portion of long-term debt$1,392 4.9 %$1,358 5.0 %
Notes payable to banks, lines of credit and other54 — %48 — %
Total notes payable and short-term borrowings
$1,446  $1,406  

Long-Term Debt
 As of
 April 30, 2025October 31, 2024
 In millions
U.S. Dollar Global Notes(1)
  
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025
$1,150 $1,150 
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026
522 521 
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027
999 999 
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028
899 899 
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029
999 999 
$500 issued at discount to par at a price of 99.732% at 5.40%, due April 2030
499 — 
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030
503 503 
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031
997 997 
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032
676 676 
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033
1,098 1,098 
$500 issued at discount to par at a price of 99.778% at 6.10%, due April 2035
499 — 
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041
1,199 1,199 
$500 issued at par at a price of 100% at 4.75%, due March 2029
3 3 
10,043 9,044 
Other borrowings at 1.45%-7.38%, due in fiscal years 2025-2031
697 645 
Fair value adjustment related to hedged debt(6)(21)
Unamortized debt issuance cost(51)(47)
Current portion of long-term debt(1,392)(1,358)
Total long-term debt$9,291 $8,263 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
In April 2025, HP completed its offering of $1.0 billion aggregate principal amount of senior unsecured notes, consisting of $500 million of 5.40% notes due April 2030 and $500 million of 6.10% notes due April 2035. HP incurred issuance costs of $9 million. HP will pay interest semi-annually on each series of the notes on April 25 and October 25, beginning October 25, 2025. In April 2025, a series of forward starting swaps and a treasury rate lock totaling $825 million notional amount were settled to mitigate the treasury rates volatility associated with this debt issuance. HP intends to use the net proceeds from the offering of the notes for general corporate purposes, which may include, without limitation, repayment and refinancing of debt (including the repayment of the Global Notes due June 2025).
As disclosed in Note 8, “Financial Instruments,” HP uses interest rate swaps to mitigate some of the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates. Interest rates shown in the table of long-term debt have not been adjusted to reflect the impact of any interest rate swaps.
Commercial Paper
As of April 30, 2025, HP maintained a U.S. commercial paper program for the issuance of U.S. dollar-denominated commercial paper up to a maximum aggregate principal amount of $6.0 billion. The principal amount outstanding under this program and certain short-term borrowings at any time cannot exceed a $6.0 billion authorization by HP’s Board of Directors.
Credit Facility
As of April 30, 2025, HP maintained a $5.0 billion 5-year sustainability-linked senior unsecured committed revolving credit facility, which HP entered into on August 1, 2024. Commitments under the revolving credit facility will be available until August 1, 2029. Commitment fees, interest rates and other terms of borrowing under the revolving credit facility vary based on HP’s external credit ratings and certain sustainability metrics. Funds borrowed under the revolving credit facility may be used for general corporate purposes.
As of April 30, 2025, HP was in compliance with the covenants in the credit agreement governing the revolving credit facility.
Available Borrowing Resources
As of April 30, 2025, HP had available borrowing resources of $1.1 billion from uncommitted lines of credit in addition to funds available under the revolving credit facility.
v3.25.1
Stockholders' Deficit
 6 Months Ended
Apr. 30, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Deficit Stockholders’ Deficit
Share Repurchase Program
HP’s share repurchase program authorizes both open market and private repurchase transactions. During the three and six months ended April 30, 2025, HP executed share repurchases of 3.1 million and 5.8 million shares and settled total shares for $0.1 billion and $0.2 billion, respectively. Share repurchases executed during the three and six months ended April 30, 2025 included 0.3 million shares settled in May 2025. During the three and six months ended April 30, 2024, HP executed share repurchases of 3.5 million and 20.5 million shares and settled total shares for $0.1 billion and $0.6 billion, respectively. Share repurchases executed during the three and six months ended April 30, 2024 included 0.3 million shares settled in May 2024.
The shares repurchased during the six months ended April 30, 2025 and 2024 were all open market repurchase transactions. As of April 30, 2025, HP had approximately $9.1 billion remaining under the share repurchase authorization approved by HP’s Board of Directors.
Changes and reclassifications related to Accumulated Other Comprehensive Loss, net of taxes
 Three months ended April 30Six months ended April 30
 2025202420252024
 In millions
Other comprehensive (loss) income, net of taxes:  
Unrealized components of available-for-sale debt securities
Balance at the beginning of period$18 $11 $14 $7 
Unrealized gains arising during the period2 — 6 4 
Unrealized components of available-for-sale debt securities, net of taxes2 — 6 4 
Balance at the end of period$20 $11 $20 $11 
Unrealized components of cash flow hedges 
Balance at the beginning of period$282 $(23)$47 $230 
Unrealized (losses) gains arising during the period
(692)151 (360)(11)
Gains reclassified into earnings(148)(5)(191)(164)
Tax effects on change in unrealized components of cash flow hedges165 (34)111 34 
Unrealized components of cash flow hedges, net of taxes(675)112 (440)(141)
Balance at the end of period$(393)$89 $(393)$89 
Unrealized components of defined benefit plans  
Balance at the beginning of period$(492)$(443)$(496)$(437)
Unrealized (losses) gains arising during the period
(2)23 (1)13 
Amortization of actuarial loss and prior service benefit(1)
5 2 10 4 
Curtailments, settlements and other1 1 — 1 
Tax effects on change in unrealized components of defined benefit plans— (6)(1)(4)
Unrealized components of defined benefit plans, net of taxes4 20 8 14 
Balance at the end of period$(488)$(423)$(488)$(423)
Cumulative translation adjustment
Balance at the beginning of period$(12)$(3)$1 $(23)
Change in cumulative translation adjustment30 (6)17 14 
Cumulative translation adjustment, net of taxes30 (6)17 14 
Balance at the end of period$18 $(9)$18 $(9)
Other comprehensive (loss) income
$(639)$126 $(409)$(109)
Accumulated other comprehensive loss$(843)$(332)$(843)$(332)
(1)These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.
v3.25.1
Earnings Per Share
 6 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
 Three months ended April 30Six months ended April 30
 2025202420252024
 In millions, except per share amounts
Numerator:  
Net earnings$406 $607 $971 $1,229 
Denominator:  
Weighted-average shares used to compute basic net EPS950 984 949 990 
Dilutive effect of employee stock plans6 6 7 6 
Weighted-average shares used to compute diluted net EPS956 990 956 996 
Net earnings per share:  
Basic$0.43 $0.62 $1.02 $1.24 
Diluted$0.42 $0.61 $1.02 $1.23 
Anti-dilutive weighted-average stock-based compensation awards(1)
10 3 7 3 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.
v3.25.1
Litigation and Contingencies
 6 Months Ended
Apr. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Litigation and Contingencies Litigation and Contingencies
HP is involved in lawsuits, claims, investigations and proceedings, including those identified below, consisting of IP, commercial, securities, employment, employee benefits and environmental matters that arise in the ordinary course of business. HP accrues a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. HP believes it has recorded adequate provisions for any such matters and, as of April 30, 2025, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Litigation, Proceedings and Investigations
Copyright Levies. Proceedings are ongoing or have been concluded involving HP in certain European countries, challenging the imposition or the modification of levies regimes upon IT equipment (such as PCs or printers) or the restrictions to exonerate the application of private copying levies on devices purchased by business users. The levies are generally based upon the number of products sold and the per-product amounts of the levies, which vary. Some European countries are expected to implement legislation to introduce or extend existing levy schemes to digital devices. HP, other companies and various industry associations have opposed the extension of levies to the digital product and certain requirements for business sales exemptions and have advocated alternative models of compensation to rights holders.
Based on the exemption of levies on business sales and industry opposition to increasing levies to digital products, HP’s assessments of the merits of various proceedings and HP’s estimates of the number of units impacted and the amounts of the levies, HP has accrued amounts that it believes are adequate to address the ongoing disputes.
India Directorate of Revenue Intelligence Proceedings. On April 30 and May 10, 2010, the India Directorate of Revenue Intelligence (the “DRI”) issued show cause notices to Hewlett-Packard India Sales Private Limited (“HP India”), a subsidiary of HP, seven HP India employees and one former HP India employee alleging that HP India underpaid customs duties while importing products and spare parts into India and seeking to recover an aggregate of approximately $370 million, plus penalties and interest. Prior to the issuance of the notices, HP India deposited approximately $16 million with the DRI and agreed to post a provisional bond in exchange for the DRI’s agreement to not seize HP India products and spare parts or interrupt business by HP India.
On April 11, 2012, the Bangalore Commissioner of Customs issued an order on the products-related notice affirming certain duties and penalties against HP India and the named individuals of approximately $386 million, of which HP India had already deposited $9 million. On December 11, 2012, HP India voluntarily deposited an additional $10 million in connection with the products-related notice. The differential duty demand is subject to interest. On April 20, 2012, the Commissioner issued an order on the parts-related notice affirming certain duties and penalties against HP India and certain of the named individuals of approximately $17 million, of which HP India had already deposited $7 million. After the order, HP India deposited an additional $3 million in connection with the parts-related notice so as to avoid certain penalties.
HP India filed appeals of the Commissioner’s orders before the Customs, Excise and Service Tax Appellate Tribunal (the “Customs Tribunal”) along with applications for waiver of the pre-deposit of remaining demand amounts as a condition for hearing the appeals. The Customs Department has also filed cross-appeals before the Customs Tribunal. On January 24, 2013, the Customs Tribunal ordered HP India to deposit an additional $24 million against the products order, which HP India deposited in March 2013. On February 7, 2014, the Customs Tribunal granted HP India’s application for extension of the stay of deposit until disposal of the appeals. On October 27, 2014, the Customs Tribunal commenced hearings on the cross-appeals of the Commissioner’s orders and rejected HP India’s request to remand the matter to the Commissioner on procedural grounds. The Customs Tribunal cancelled hearings to reconvene in 2015, 2016 and January 2019. On January 20, 2021, the Customs Tribunal held a virtual hearing during which the judge allowed HP’s application for a physical hearing on the merits as soon as practicable, which will be scheduled when physical hearings resume at court. In unrelated, third-party proceedings, the Supreme Court of India has resolved certain jurisdictional questions to the authority of the Directorate of Revenue Intelligence, issues which HP also raised in its appeal to the Customs Tribunal. In late 2024, those jurisdictional questions were resolved. A hearing on the merits of HP and DRI’s appeals was held before the Customs Tribunal from April 21 through May 2, 2025. The Customs Tribunal is anticipated to hold additional hearings on the appeal in June 2025 and then take the matter under submission. Pursuant to the separation and distribution agreement, Hewlett Packard Enterprise has agreed to indemnify HP in part, based on the extent to which any liability arises from the products and spare parts of Hewlett Packard Enterprise’s businesses.
Media Content Protection LLC Patent Litigation (formerly Philips Patent Litigation). In September 2020, Koninklijke Philips N.V. and Philips North America LLC (collectively, “Philips”) filed a complaint against HP for patent infringement in federal court for the District of Delaware and filed a companion complaint with the U.S. International Trade Commission (“ITC”) pursuant to Section 337 of the Tariff Act against HP and 8 other sets of respondents. Both complaints allege that certain digital video-capable devices and components thereof infringe four of Philips’ patents. In October 2020, the ITC instituted an investigation, and Philips later withdrew two of the four patents. On March 23, 2022, the ITC rendered a final determination that no violation of Section 337 has occurred. Philips did not appeal and elected to resume litigation with its case in federal court. Philips seeks unspecified damages and an injunction against HP, and the prior stay has been lifted. On August 10, 2023, HP filed a motion for summary judgment of indefiniteness for all asserted claims. On July 1, 2024, the district court denied the motion without prejudice to renew. Philips conveyed the patents asserted in the district court action to Media Content Protection LLC (“MCP”), and MCP was substituted as plaintiff in place of Philips.
York County on behalf of the County of York Retirement Fund v. HP Inc., et al., and related proceedings. On November 5, 2020, York County, on behalf of the County of York Retirement Fund, filed a putative class action complaint against HP, Dion Weisler, and Catherine Lesjak in federal court in the Northern District of California. The court appointed Maryland Electrical Industry Pension Fund as Lead Plaintiff. Lead Plaintiff filed a consolidated complaint, which additionally names as defendants Enrique Lores and Richard Bailey. The complaint alleges, among other things, that from November 5, 2015 to June 21, 2016, HP and the named current and former officers violated Sections 10(b) and 20(a) of the Exchange Act by concealing material information and making false statements about HP’s printing supplies business (“Securities Class Action”). Plaintiffs seek compensatory damages and other relief. HP and the named officers filed a motion to dismiss the complaint for failure to state a claim upon which relief can be granted. On March 3, 2022, the court granted the motion to dismiss with prejudice. Plaintiffs appealed the decision. On April 11, 2023, the appellate court reversed the district court’s decision and remanded the case to the district court for further proceedings consistent with the appellate opinion, including consideration of HP’s other arguments for dismissal. On July 21, 2023, HP and the named officers filed a renewed motion to dismiss. On March 27, 2024, the district court issued an order granting in part and denying in part the motion to dismiss. On August 8, 2024, the Court of Appeals for the Ninth Circuit granted HP’s petition for permission to appeal. On October 28, 2024, HP filed its appeal, which is awaiting appellate court oral argument that has not yet been scheduled. On May 17, 2021, stockholder Scott Franklin filed a derivative complaint against certain current and former officers and directors in federal court in the District of Delaware. Plaintiff purports to bring the action on behalf of HP, which he has named as a nominal defendant, and he makes substantially the same factual allegations as in the York County securities complaint, bringing claims for breach of fiduciary duty and violations of securities laws. The derivative plaintiff seeks compensatory damages, governance reforms, and other relief. By court order following stipulations by the parties, the case was transferred to the Northern District of California, and the case was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. On January 13, 2022, stockholder Gerald Lovoi filed a derivative complaint in federal court in the Northern District of California against the same current and former officers and directors named in the Franklin action. The complaint alleges the same basic claims based on the same alleged conduct as the Franklin action and seeks similar relief. By stipulation of the parties, the Lovoi action was stayed pending a ruling on the motion to dismiss in York County and exhaustion of all related appeals. On May 31, 2024, the court adopted a stipulation in which the derivative plaintiffs and defendants agreed to consolidate the derivative proceedings, close the Lovoi action, and extend the current stay through summary judgment in the Securities Class Action.
Legal Proceedings re Authentication of Supplies. Since 2016, HP has from time to time been named in civil litigation, or been the subject of government investigations, involving supplies authentication protocols used in certain HP printers in multiple geographies, including but not limited to the United States, Italy, Israel, the Netherlands, Australia and New Zealand. The supplies authentication protocols are often referred to as Dynamic Security. The core allegations in these proceedings claim misleading or inadequate consumer notifications and permissions pertaining to the use of Dynamic Security, the installation of firmware updates, or the potential inability of cartridges with clone chips or circuitry to work in HP printers with Dynamic Security. Plaintiffs base or have based their claims on various legal theories, including but not limited to unfair competition, computer trespass, and similar statutory claims. Among other relief, Plaintiffs have sought or seek money damages and in certain cases have or may seek injunctive relief against the use or operation of Dynamic Security or relief requiring interoperability. If HP is not successful in its defense of these cases or investigations, it could be subject to damages, penalties, significant settlement demands, or injunctive relief that may be costly or may disrupt operations. Certain of these proceedings in the United States, Italy, the Netherlands, Israel, Australia and New Zealand have been resolved, have concluded, or have concluded subject only to HP’s pending appeal. Digital Revolution B.V. (trading as 123Inkt) filed civil litigation, including competition claims, against HP Nederlands B.V., et al. (Netherlands) in March 2020. HP substantially prevailed before the trial court, and both parties appealed. On November 19, 2024, the court of appeal issued a decision rejecting competition claims against HP and providing that use of Dynamic Security by HP is not unlawful. On February 18, 2025, Digital Revolution filed a cassation appeal against the decision before the Dutch Supreme Court. In addition, two putative class actions have been filed against HP, one in federal court in California, in December 2020, and one in federal court in Illinois, in January 2024, arising out of the use of Dynamic Security firmware updates in HP printers. Plaintiffs in these cases seek compensatory damages, restitution, injunctive relief against alleged unfair and anticompetitive business practices, and other relief. In the December 2020 case, the parties have finalized a settlement agreement, and the court granted final approval of the settlement and dismissed the case with prejudice on March 18, 2025. The January 2024 case is in its early stages.
Autonomy-Related Legal Proceedings. In 2015, four former Hewlett Packard Company subsidiaries that became subsidiaries of Hewlett Packard Enterprise at the time of the Separation (Autonomy Corporation Limited, Hewlett Packard Vision BV, Autonomy Systems Limited, and Autonomy, Inc., hereinafter the “Claimants”) initiated civil proceedings in the U.K. High Court of Justice against two members of Autonomy’s former management, Michael Lynch and Sushovan Hussain, for breach of their fiduciary duties in causing Autonomy group companies to engage in improper transactions and accounting practices before and in connection with the 2011 acquisition of Autonomy. Trial concluded in January 2020. In May 2022, the court issued its liability judgment, finding that the Claimants had succeeded on substantially all claims and that Messrs. Lynch and Hussain engaged in fraud, and dismissing a counterclaim filed by Mr. Lynch. The court deferred the issue of damages to further proceedings, but indicated that damages awarded may be substantially less than was claimed. In February 2024, the court held a two-week trial on damages, the Claimants sought recovery for $4 billion in losses, and the court took the issue under advisement. Litigation is unpredictable, and there can be no assurance of a recovery of damages or as to how any award of damages will compare with the amount claimed. The amount ultimately awarded, if any, would be recorded in the period received. No adjustment has been recorded in the financial statements in relation to this potential award. Pursuant to the terms of the separation and distribution agreement, HP and Hewlett Packard Enterprise will share equally in any recovery. In May 2025, Claimants reached an agreement with Mr. Hussain to resolve claims against him.
Litigation with Wilus Institute of Standards and Technology, Inc. and Sisvel International S.A. Since September 13, 2024, Wilus Institute of Standards and Technology, Inc. (“Wilus”) has filed three patent infringement lawsuits against HP in the Eastern District of Texas seeking monetary damages, injunctions and other relief. The complaints allege that HP products that are compliant with the Wi-Fi 6 (801.11.ax) standard infringe patents owned by Wilus. Wilus is a member of the Wi-Fi 6 patent pool administered by Sisvel International S.A. (“Sisvel”), and the patents at issue in the lawsuits are in the Sisvel Wi-Fi 6 patent pool. In December 2024, HP answered the complaints and filed counterclaims against Wilus and Sisvel, alleging that Wilus and Sisvel violated their obligations to license standard-essential patents on fair, reasonable and non-discrimination (“FRAND”) terms, and seeking a court determination of the proper FRAND rate.
Environmental
    HP is, and may become a party to, proceedings brought by U.S., state, or other governmental entities or private third parties under federal, state, local, or foreign environmental laws, including the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), known as “Superfund,” or state laws similar to CERCLA. HP is also conducting environmental investigations or remediation at several current or former operating sites and former disposal sites pursuant to administrative orders or consent agreements with environmental agencies.
v3.25.1
Guarantees, Indemnifications and Warranties
 6 Months Ended
Apr. 30, 2025
Guarantees [Abstract]  
Guarantees, Indemnifications and Warranties Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.
Indemnifications 
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
HP’s aggregate product warranty liabilities and changes were as follows:
 Six months ended April 30, 2025
 In millions
Balance at beginning of period$550 
Accruals for warranties issued322 
Adjustments related to pre-existing warranties (including changes in estimates)(4)
Settlements made
(384)
Balance at end of period$484 
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Jan. 31, 2025
Apr. 30, 2024
Jan. 31, 2024
Apr. 30, 2025
Apr. 30, 2024
Pay vs Performance Disclosure            
Net earnings $ 406 $ 565 $ 607 $ 622 $ 971 $ 1,229
v3.25.1
Insider Trading Arrangements
 3 Months Ended
Apr. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Basis of Presentation (Policies)
 6 Months Ended
Apr. 30, 2025
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying Consolidated Condensed Financial Statements of HP and its wholly owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements for the fiscal year ended October 31, 2024 in HP’s Annual Report on Form 10-K, filed on December 13, 2024. The Consolidated Condensed Balance Sheet for October 31, 2024 was derived from audited financial statements.
Principles of Consolidation
Principles of Consolidation
The Consolidated Condensed Financial Statements include the accounts of HP and its subsidiaries and affiliates in which HP has a controlling financial interest or is the primary beneficiary. All intercompany balances and transactions have been eliminated.
Use of Estimates
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in HP’s Consolidated Condensed Financial Statements and accompanying notes. Actual results may differ materially from those estimates.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Adopted Accounting Pronouncements
In September 2022, the Financial Accounting Standards Board (“FASB”) issued guidance that enhances the transparency about the use of supplier finance programs. Under the new guidance, companies that use a supplier finance program in connection with the purchase of goods or services are required to disclose information about those programs to allow users of financial statements to understand the nature, activity during the period, changes from period to period, and potential magnitude. HP adopted this guidance in the first quarter of fiscal year 2024, except for the disclosure on rollforward information which will be adopted in its fiscal year 2025 Form 10-K, in line with the effective adoption dates prescribed by the FASB. See Note 6, “Supplementary Financial Information,” for additional disclosure related to HP’s supplier finance programs.
Recently Issued Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued guidance that requires disaggregation of specific expense categories in disclosures within the footnotes to the financial statements on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2028 and all interim periods thereafter on a prospective basis. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In December 2023, the FASB issued guidance that enhances the transparency of income tax disclosures by expanding annual disclosure requirements related to the rate reconciliation and income taxes paid. HP is required to adopt this guidance for its annual period ending October 31, 2026. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
In November 2023, the FASB issued guidance that updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance on an annual and interim basis. HP is required to adopt this guidance for its annual period ending October 31, 2025 and all interim periods thereafter. Early adoption is permitted. HP is currently evaluating the impact of this guidance on its disclosures.
Segment Information
HP does not allocate certain operating expenses, which it manages at the corporate level, to its segments. These unallocated amounts include expenses such as certain corporate governance costs and infrastructure investments, stock-based compensation expense, restructuring and other charges, acquisition and divestiture charges, amortization of intangible assets, and certain litigation charges.
Employer Contributions and Funding Policy
Employer Contributions and Funding Policy
HP’s policy is to fund its pension plans so that it makes at least the minimum contribution required by local government, funding and taxing authorities.
Taxes on Earnings HP recognizes interest income from favorable settlements and interest expense and penalties accrued on unrecognized tax benefits in the provision for taxes in the Consolidated Condensed Statements of Earnings.
Supplementary Financial Information
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Condensed Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Condensed Balance Sheets. The recourse obligations as of April 30, 2025 and October 31, 2024 were not material.
Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date.
Fair Value Hierarchy
HP uses valuation techniques that are based upon observable and unobservable inputs. Observable inputs are developed using market data such as publicly available information and reflect the assumptions market participants would use, while unobservable inputs are developed using the best information available about the assumptions market participants would use. Assets and liabilities are classified in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement:
Level 1—Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2—Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability and market-corroborated inputs.
Level 3—Unobservable inputs for the asset or liability.
The fair value hierarchy gives the highest priority to observable inputs and lowest priority to unobservable inputs.
Valuation Techniques
Cash Equivalents and Investments: HP holds time deposits, money market funds, mutual funds, other debt securities primarily consisting of corporate and foreign government notes and bonds, and common stock and equivalents. HP values cash equivalents and equity investments using quoted market prices, alternative pricing sources, including net asset value, or models utilizing market observable inputs. The fair value of debt investments is based on quoted market prices or model-driven valuations using inputs primarily derived from or corroborated by observable market data and, in certain instances, valuation models that utilize assumptions which cannot be corroborated with observable market data.
Derivative Instruments: HP uses industry standard valuation models to measure fair value. Where applicable, these models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves, HP and counterparty credit risk, foreign exchange rates, and forward and spot prices for currencies and interest rates. See Note 8, “Financial Instruments” for a further discussion of HP’s use of derivative instruments.
Other Fair Value Disclosures
Short- and Long-Term Debt: HP estimates the fair value of its debt primarily using an expected present value technique, which is based on observable market inputs using interest rates currently available to companies of similar credit standing for similar terms and remaining maturities and considering its own credit risk. The portion of HP’s debt that is hedged is reflected in the Consolidated Condensed Balance Sheets as an amount equal to the debt’s carrying amount and a fair value adjustment representing changes in the fair value of the hedged debt obligations arising from movements in benchmark interest rates. The fair value of HP’s short- and long-term debt was $10.4 billion as compared to its carrying amount of $10.7 billion as of April 30, 2025. The fair value of HP’s short- and long-term debt was $9.4 billion as compared to its carrying value of $9.7 billion as of October 31, 2024. If measured at fair value in the Consolidated Condensed Balance Sheets, short- and long-term debt would be classified in Level 2 of the fair value hierarchy.
Other Financial Instruments: For the balance of HP’s financial instruments, primarily accounts receivable, accounts payable and financial liabilities included in Other current liabilities on the Consolidated Condensed Balance Sheets, the carrying amounts approximate fair value due to their short maturities. If measured at fair value in the Consolidated Condensed Balance Sheets, these other financial instruments would be classified as Level 2 or Level 3 of the fair value hierarchy.
Non-Marketable Equity Investments and Non-Financial Assets: HP’s non-marketable equity investments are measured at cost less impairment, adjusted for observable price changes. HP’s non-financial assets, such as intangible assets, goodwill and property, plant and equipment, are recorded at fair value in the period an impairment charge is recognized. If measured at fair value in the Consolidated Condensed Balance Sheets these would generally be classified within Level 3 of the fair value hierarchy.
Cash Equivalents and Available-for-Sale Investments All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents.
Non-Marketable Equity Securities Investments Non-marketable equity securities in privately held companies are included in Other current and non-current assets in the Consolidated Condensed Balance Sheets.
Derivative Instruments
Derivative Instruments
HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps, treasury rate locks, forward starting swaps and option contracts to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. HP may designate its derivative contracts as fair value hedges or cash flow hedges and classifies the cash flows with the activities that correspond to the underlying hedged items. Additionally, for derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP’s custodian to hold collateral from, or require HP to post collateral to, counterparties when the net fair value of financial instruments fluctuates from contractually established thresholds. The Company includes gross collateral posted and received in other current assets and other current liabilities in the Consolidated Condensed Balance Sheets, respectively. The fair value of derivatives with credit contingent features in a net liability position was $506 million and $59 million as of April 30, 2025 and as of October 31, 2024, respectively, all of which were fully collateralized within two business days.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of April 30, 2025 and October 31, 2024.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in benchmark interest rates on HP’s future interest payments.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts, option contracts, treasury rate locks and forward starting swaps designated as cash flow hedges to protect against the foreign currency exchange and interest rate risks inherent in its forecasted products net revenue, cost of products net revenue, operating expenses and debt issuance. HP’s foreign currency cash flow hedges mature predominantly within twelve months; however, hedges related to long-term procurement arrangements, contractual pricing and/or business unit specific exposures may extend several years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of Stockholders’ deficit in the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the changes in the fair value of the derivative instrument in the same financial statement line item as changes in the fair value of the hedged item.
In April 2025, a series of forward starting swaps and a treasury rate lock totaling $825 million notional amount were settled upon the issuance of the senior unsecured notes resulting in a net gain of $6 million recognized in Accumulated other comprehensive loss. The gain will be reclassified to Interest and other, net over the life of the related debt.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP also uses total return swaps to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options, forward contracts and forward starting swaps designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
Offsetting of Derivatives Instruments
Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements.
Earnings Per Share
HP calculates basic net EPS using net earnings and the weighted-average number of shares outstanding during the reporting period. Diluted net EPS includes any dilutive effect of restricted stock units, stock options, performance-based awards and shares purchased under the 2021 employee stock purchase plan.
Litigation and Contingencies April 30, 2025, it was not reasonably possible that a material loss had been incurred in excess of the amounts recognized in HP’s financial statements. HP reviews these matters at least quarterly and adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. Pursuant to the separation and distribution agreement entered into with Hewlett Packard Enterprise Company (“Hewlett Packard Enterprise”), HP shares responsibility with Hewlett Packard Enterprise for certain matters, as indicated below, and Hewlett Packard Enterprise has agreed to indemnify HP in whole or in part with respect to certain matters. Based on its experience, HP believes that any damage amounts claimed in the specific matters discussed below are not a meaningful indicator of HP’s potential liability. Litigation is inherently unpredictable. However, HP believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies.
Guarantees, Indemnifications and Warranties
Guarantees
In the ordinary course of business, HP may issue performance guarantees to certain of its clients, customers and other parties pursuant to which HP has guaranteed the performance obligations of third parties. Some of those guarantees may be backed by standby letters of credit or surety bonds. In general, HP would be obligated to perform over the term of the guarantee in the event a specified triggering event occurs as defined by the guarantee. HP believes the likelihood of having to perform under a material guarantee is remote.
Cross-Indemnifications with Hewlett Packard Enterprise
On November 1, 2015, Hewlett-Packard Company completed the separation of Hewlett Packard Enterprise, Hewlett-Packard Company’s former enterprise technology infrastructure, software, services and financing businesses. The separation and distribution agreement provides for cross-indemnities between HP and Hewlett Packard Enterprise for liabilities allocated to the respective party pursuant to the terms of such agreement. For information on cross-indemnifications with Hewlett Packard Enterprise for litigation matters, see Note 12, “Litigation and Contingencies”.
Indemnifications 
In the ordinary course of business, HP enters into contractual arrangements under which HP may agree to indemnify a third-party to such arrangement from any losses incurred relating to the services they perform on behalf of HP or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. HP also provides indemnifications to certain vendors and customers against claims of intellectual property infringement made by third parties arising from the vendors’ and customers’ use of HP’s software products and services and certain other matters. Some indemnifications may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.
HP records tax indemnification receivables from various third parties for certain tax liabilities that HP is jointly and severally liable for, but for which it is indemnified by those same third parties under existing legal agreements. HP records a tax indemnification payable to various third parties under these agreements when management believes that it is both probable that a liability has been incurred and the amount can be reasonably estimated. The actual amount that the third parties pay or may be obligated to pay HP could vary depending on the outcome of certain unresolved tax matters, which may not be resolved for several years.
Warranties
HP accrues the estimated cost of product warranties at the time it recognizes revenue. HP engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers; however, contractual warranty terms, repair costs, product call rates, average cost per call, current period product shipments and ongoing product failure rates, as well as specific product class failures outside of HP’s baseline experience, affect the estimated warranty obligation.
v3.25.1
Segment Information (Tables)
 6 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Schedule of Reconciliation of Revenue from Segment Operating Results to HP Consolidated Results
Segment operating results and the reconciliation to HP consolidated results were as follows:
 Three months ended April 30Six months ended April 30
 2025202420252024
In millions
Net revenue:
Commercial PS$6,786 $6,242 $13,431 $12,287 
Consumer PS2,238 2,184 4,817 4,948 
Personal Systems9,024 8,426 18,248 17,235 
Supplies2,725 2,864 5,551 5,727 
Commercial Printing1,167 1,205 2,311 2,432 
Consumer Printing289 299 588 584 
Printing4,181 4,368 8,450 8,743 
Corporate Investments16 5 27 7 
Total segment net revenue13,221 12,799 26,725 25,985 
Other(1)1 (1)— 
Total net revenue$13,220 $12,800 $26,724 $25,985 
  
Earnings before taxes:
Personal Systems$409 $508 $916 $1,045 
Printing814 829 1,624 1,701 
Corporate Investments(37)(30)(64)(67)
Total segment earnings from operations1,186 1,307 2,476 2,679 
Corporate and unallocated costs and other(85)(88)(199)(177)
Stock-based compensation expense(140)(94)(332)(271)
Restructuring and other charges(122)(71)(192)(134)
Acquisition and divestiture charges(17)(22)(23)(49)
Amortization of intangible assets(65)(80)(128)(161)
Certain litigation charges
(103)— (103)— 
Interest and other, net(148)(155)(289)(297)
Total earnings before taxes$506 $797 $1,210 $1,590 
Schedule of Reconciliation of Operating Profit (Loss) from Segment Operating Results to HP Consolidated Results
Segment operating results and the reconciliation to HP consolidated results were as follows:
 Three months ended April 30Six months ended April 30
 2025202420252024
In millions
Net revenue:
Commercial PS$6,786 $6,242 $13,431 $12,287 
Consumer PS2,238 2,184 4,817 4,948 
Personal Systems9,024 8,426 18,248 17,235 
Supplies2,725 2,864 5,551 5,727 
Commercial Printing1,167 1,205 2,311 2,432 
Consumer Printing289 299 588 584 
Printing4,181 4,368 8,450 8,743 
Corporate Investments16 5 27 7 
Total segment net revenue13,221 12,799 26,725 25,985 
Other(1)1 (1)— 
Total net revenue$13,220 $12,800 $26,724 $25,985 
  
Earnings before taxes:
Personal Systems$409 $508 $916 $1,045 
Printing814 829 1,624 1,701 
Corporate Investments(37)(30)(64)(67)
Total segment earnings from operations1,186 1,307 2,476 2,679 
Corporate and unallocated costs and other(85)(88)(199)(177)
Stock-based compensation expense(140)(94)(332)(271)
Restructuring and other charges(122)(71)(192)(134)
Acquisition and divestiture charges(17)(22)(23)(49)
Amortization of intangible assets(65)(80)(128)(161)
Certain litigation charges
(103)— (103)— 
Interest and other, net(148)(155)(289)(297)
Total earnings before taxes$506 $797 $1,210 $1,590 
v3.25.1
Restructuring and Other Charges (Tables)
 6 Months Ended
Apr. 30, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Activities by Plan
HP’s restructuring activities summarized by plan were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans(1)
Total
In millions
Accrued balance as of October 31, 2024$120 $11 $7 $138 
Charges141 20 — 161 
Cash payments(110)(6)(2)(118)
Non-cash and other adjustments1 (16)— (15)
Accrued balance as of April 30, 2025$152 $9 $5 $166 
Total costs incurred to date as of April 30, 2025$748 $77 $878 $1,703 
Reflected in the Consolidated Condensed Balance Sheets
Other current liabilities$152 $3 $5 $160 
Other non-current liabilities$— $6 $— $6 
Accrued balance as of October 31, 2023$88 $18 $2 $108 
Charges93 6 3 102 
Cash payments(100)(9)(3)(112)
Non-cash and other adjustments2 (2)(2)(2)
Accrued balance as of April 30, 2024$83 $13 $— $96 
HP’s restructuring charges for the three months ended April 30, 2025 summarized by the plans outlined below were as follows:
Fiscal 2023 Plan
Severance and EERNon-labor
Other prior-year plans (1)
Total
In millions
For the three months ended April 30, 2025$97 $8 $— $105 
(1)     Primarily includes the fiscal 2020 plan along with other legacy plans, all of which are substantially complete. HP does not expect any further material activity associated with these plans.
v3.25.1
Retirement and Post-Retirement Benefit Plans (Tables)
 6 Months Ended
Apr. 30, 2025
Retirement Benefits [Abstract]  
Schedule of Components of Pension and Post-Retirement Benefit (Credit)
The components of HP’s pension and post-retirement benefit (credit) cost recognized in the Consolidated Condensed Statements of Earnings were as follows:
 Three months ended April 30
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost-Retirement Benefit Plans
 202520242025202420252024
 In millions
Service cost$— $— $10 $9 $— $— 
Interest cost53 57 10 11 3 4 
Expected return on plan assets(62)(62)(13)(13)(3)(4)
Amortization and deferrals:      
Actuarial loss (gain)8 7 2 — (5)(4)
Prior service cost (credit)— — 1 1 (1)(2)
Net periodic benefit (credit) cost(1)2 10 8 (6)(6)
Settlement loss— — 1 1 — — 
Total periodic benefit (credit) cost$(1)$2 $11 $9 $(6)$(6)
 Six months ended April 30
 U.S. Defined Benefit PlansNon-U.S. Defined Benefit PlansPost-Retirement Benefit Plans
 202520242025202420252024
 In millions
Service cost$— $— $19 $18 $— $— 
Interest cost106 114 20 23 7 8 
Expected return on plan assets(121)(123)(27)(26)(7)(8)
Amortization and deferrals:
Actuarial loss (gain)15 14 4 — (9)(8)
Prior service cost (credit)— — 3 3 (3)(5)
Net periodic benefit cost (credit)$— $5 $19 $18 $(12)$(13)
Settlement loss — — 1 1 — — 
Total periodic benefit cost (credit)$— $5 $20 $19 $(12)$(13)
v3.25.1
Supplementary Financial Information (Tables)
 6 Months Ended
Apr. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents and Restricted Cash
 As of
 April 30, 2025October 31, 2024
 In millions
Cash and cash equivalents$2,697 $3,238 
Restricted cash(1)
33 15 
$2,730 $3,253 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Schedule of Restricted Cash
Cash, Cash Equivalents and Restricted Cash
 As of
 April 30, 2025October 31, 2024
 In millions
Cash and cash equivalents$2,697 $3,238 
Restricted cash(1)
33 15 
$2,730 $3,253 
(1)    Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold.
Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes
The allowance for credit losses related to accounts receivable and changes were as follows:
 Six months ended April 30, 2025
 In millions
Balance at beginning of period$83 
Current-period allowance for credit losses6 
Deductions, net of recoveries(4)
Balance at end of period$85 
Schedule of Trade Receivables Sold and Cash Received
The following is a summary of the activity under these arrangements:
Three months ended April 30Six months ended April 30
 2025 20242025 2024
 In millions
Balance at beginning of period(1)
$133 $212 $284 $141 
Trade receivables sold3,125 2,846 6,174 6,145 
Cash receipts(3,056)(2,873)(6,247)(6,106)
Foreign currency and other15 (4)6 1 
Balance at end of period(1)
$217 $181 $217 $181 
(1)    Amounts outstanding from third parties reported in Accounts receivable in the Consolidated Condensed Balance Sheets.
Schedule of Inventory
Inventory
 As of
 April 30, 2025October 31, 2024
 In millions
Finished goods$4,469 $4,338 
Purchased parts and fabricated assemblies3,706 3,382 
$8,175 $7,720 
Schedule of Other Current Assets
Other Current Assets
 As of
 April 30, 2025October 31, 2024
 In millions
Supplier and other receivables$1,404 $2,180 
Prepaid and other current assets1,840 1,462 
Value-added taxes receivable973 1,028 
$4,217 $4,670 
Schedule of Property, Plant and Equipment, Net
Property, Plant and Equipment, Net
 As of
 April 30, 2025October 31, 2024
 In millions
Land, buildings and leasehold improvements$2,560 $2,527 
Machinery and equipment, including equipment held for lease5,746 5,465 
8,306 7,992 
Accumulated depreciation(5,355)(5,078)
$2,951 $2,914 
Schedule of Other Non-Current Assets
Other Non-Current Assets
 As of
 April 30, 2025October 31, 2024
 In millions
Deferred tax assets$3,513 $3,311 
Intangible assets1,228 1,319 
Right-of-use assets1,104 1,165 
Prepaid pension and post-retirement benefit assets389 362 
Deposits and prepaid305 322 
Other1,138 1,129 
$7,677 $7,608 
Schedule of Other Current Liabilities
Other Current Liabilities
 As of
 April 30, 2025October 31, 2024
 In millions
Sales and marketing programs$2,826 $3,060 
Deferred revenue1,495 1,446 
Other accrued taxes1,141 1,233 
Employee compensation and benefits743 970 
Warranty429 486 
Operating lease liabilities413 443 
Tax liability263 291 
Other2,605 2,449 
$9,915 $10,378 
Schedule of Other Non-Current Liabilities
Other Non-Current Liabilities
 As of
 April 30, 2025October 31, 2024
In millions
Deferred revenue$1,544 $1,487 
Operating lease liabilities766 787 
Tax liability755 839 
Pension, post-retirement, and post-employment liabilities597 607 
Deferred tax liability29 31 
Other537 531 
$4,228 $4,282 
Schedule of Interest and Other, Net
Interest and Other, Net
 Three months ended April 30Six months ended April 30
 202520242025 2024
 In millions
Interest expense on borrowings$(114)$(122)$(218)$(238)
Factoring costs(32)(40)(69)(79)
Non-operating retirement-related credits4 2 10 6 
Other, net(6)5 (12)14 
$(148)$(155)$(289)$(297)
Schedule of Net Revenue by Region
Net Revenue by Region
Three months ended April 30Six months ended April 30
 202520242025 2024
 In millions
Americas$5,793 $5,591 $11,312 $10,999 
Europe, Middle East and Africa
4,393 4,373 9,147 9,041 
Asia-Pacific and Japan3,034 2,836 6,265 5,945 
Total net revenue$13,220 $12,800 $26,724 $25,985 
v3.25.1
Fair Value (Tables)
 6 Months Ended
Apr. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents HP’s assets and liabilities that are measured at fair value on a recurring basis:
 As of April 30, 2025As of October 31, 2024
 Fair Value Measured UsingFair Value Measured Using
 Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
 In millions
Assets:        
Cash Equivalents:        
Time deposits
$— $1,237 $— $1,237 $— $1,012 $— $1,012 
Government debt(1)
721 — — 721 1,332 — — 1,332 
Available-for-Sale Investments:
Financial institution instruments— 3 — 3 — 3 — 3 
Marketable securities and mutual funds(2)
53 123 — 176 54 130 — 184 
Derivative Instruments:    
Interest rate contracts— — — — — 4 — 4 
Foreign currency contracts— 63 — 63 — 225 — 225 
Other derivatives— 3 — 3 — — — — 
Total assets$774 $1,429 $— $2,203 $1,386 $1,374 $— $2,760 
Liabilities:        
Derivative Instruments:        
Interest rate contracts$— $6 $— $6 $— $22 $— $22 
Foreign currency contracts— 565 — 565 — 158 — 158 
Other derivatives— — — — — 2 — 2 
Total liabilities$— $571 $— $571 $— $182 $— $182 
(1)    Government debt includes instruments such as U.S. treasury notes, U.S. agency securities and non-U.S. government bonds. Money market funds invested in government debt and traded in active markets are included in Level 1.
(2)    As of April 30, 2025 and October 31, 2024, $69 million and $78 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
v3.25.1
Financial Instruments (Tables)
 6 Months Ended
Apr. 30, 2025
Investments, All Other Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Investments
Cash Equivalents and Available-for-Sale Investments
 As of April 30, 2025As of October 31, 2024
 CostGross Unrealized GainGross Unrealized LossFair ValueCostGross Unrealized GainGross Unrealized LossFair Value
 In millions
Cash Equivalents:        
Time deposits
$1,237 $— $— $1,237 $1,012 $— $— $1,012 
Government debt721 — — 721 1,332 — — 1,332 
Total cash equivalents1,958 — — 1,958 2,344 — — 2,344 
Available-for-Sale Investments:     
Financial institution instruments3 — — 3 3 — — 3 
Marketable securities and mutual funds(1)
112 64 — 176 115 69 — 184 
Total available-for-sale investments115 64 — 179 118 69 — 187 
Total cash equivalents and available-for-sale investments$2,073 $64 $— $2,137 $2,462 $69 $— $2,531 
(1)    As of April 30, 2025 and October 31, 2024, $69 million and $78 million, respectively, of debt securities were restricted to fund benefits received by qualifying employees under a sponsored defined benefit plan.
Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of April 30, 2025
 Amortized CostFair Value
 In millions
Due in one year$17 $17 
Due in one to five years55 55 
$72 $72 
Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:
 As of April 30, 2025As of October 31, 2024
 Outstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current LiabilitiesOutstanding Gross NotionalOther Current AssetsOther Non-Current AssetsOther Current LiabilitiesOther Non-Current Liabilities
 In millions
Derivatives designated as hedging instruments     
Fair value hedges:     
Interest rate contracts$750 $— $— $6 $— $750 $— $— $11 $10 
Cash flow hedges:
Foreign currency contracts15,443 40 9 456 91 14,563 169 36 117 34 
Interest rate contracts— — — — — 500 — 4 — 1 
Total derivatives designated as hedging instruments16,193 40 9 462 91 15,813 169 40 128 45 
Derivatives not designated as hedging instruments    
Foreign currency contracts4,571 14 — 18 — 4,284 20 — 7 — 
Other derivatives146 3 — — — 156 — — 2 — 
Total derivatives not designated as hedging instruments4,717 17 — 18 — 4,440 20 — 9 — 
Total derivatives$20,910 $57 $9 $480 $91 $20,253 $189 $40 $137 $45 
Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Assets As of April 30, 2025 and October 31, 2024, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of April 30, 2025       
Derivative assets$66 $— $66 $59 $— (1)$7 
Derivative liabilities$571 $— $571 $59 $535 (2)$(23)
As of October 31, 2024       
Derivative assets$229 $— $229 $113 $88 (1)$28 
Derivative liabilities$182 $— $182 $113 $61 (2)$8 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements, Offsetting Liabilities As of April 30, 2025 and October 31, 2024, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 In the Consolidated Condensed Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
Gross Amounts Not Offset
 Gross Amount
Recognized		Gross Amount
Offset		Net Amount
Presented		Derivatives
Financial
Collateral		 Net Amount
 In millions
As of April 30, 2025       
Derivative assets$66 $— $66 $59 $— (1)$7 
Derivative liabilities$571 $— $571 $59 $535 (2)$(23)
As of October 31, 2024       
Derivative assets$229 $— $229 $113 $88 (1)$28 
Derivative liabilities$182 $— $182 $113 $61 (2)$8 
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by HP including any re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset as of, generally, two business days prior to the respective reporting date.
Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship were as follows:
Derivative InstrumentHedged ItemLocationYearTotal amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recordedGain/(loss) recognized in earnings on derivative instrumentsGain/(loss) recognized in earnings on hedged item
In millions
Three months ended April 30
Interest rate contractFixed-rate debtInterest and other, net2025$(148)$8 $(8)
2024$(155)$— $— 
Six months ended April 30
Interest rate contractFixed-rate debtInterest and other, net2025$(289)$15 $(15)
2024$(297)$15 $(15)
Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income
The pre-tax effect of derivative instruments in cash flow hedging relationships included in Accumulated other comprehensive (loss) income was as follows:
Three months ended April 30Six months ended April 30
2025202420252024
In millions
Gain/(loss) recognized in Accumulated other comprehensive (loss) income on derivatives:
Foreign currency contracts$(687)$151 $(363)$(11)
Interest rate contracts(5)— 3 — 
Total$(692)$151 $(360)$(11)
Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings
The pre-tax effect of derivative instruments in cash flow hedging relationships included in earnings were as follows:
Gain/(loss) reclassified from Accumulated 
other comprehensive (loss) income into earnings
Three months ended April 30Six months ended April 30
2025202420252024
In millions
Products net revenue$167 $39 $234 $238 
Cost of products net revenue(23)(36)(50)(76)
Operating expenses1 (1)1 (4)
Interest and other, net3 3 6 6 
Total$148 $5 $191 $164 
Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments not designated as hedging instruments recognized in Interest and other, net in the Consolidated Condensed Statements of Earnings as follows:
Gain/(loss) recognized in earnings on derivative instrument
 Three months ended April 30Six months ended April 30
 Location2025202420252024
  In millions
Foreign currency contractsInterest and other, net$(11)$6 $(14)$7 
Other derivativesInterest and other, net1 (6)5 (2)
Total $(10)$— $(9)$5 
v3.25.1
Borrowings (Tables)
 6 Months Ended
Apr. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Notes Payable and Short-Term Borrowings
Notes Payable and Short-Term Borrowings
 As of April 30, 2025As of October 31, 2024
 Amount
Outstanding		Weighted-Average
Interest Rate		Amount
Outstanding		Weighted-Average
Interest Rate
 In millions
Current portion of long-term debt$1,392 4.9 %$1,358 5.0 %
Notes payable to banks, lines of credit and other54 — %48 — %
Total notes payable and short-term borrowings
$1,446  $1,406  
Schedule of Long-Term Debt
Long-Term Debt
 As of
 April 30, 2025October 31, 2024
 In millions
U.S. Dollar Global Notes(1)
  
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025
$1,150 $1,150 
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026
522 521 
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027
999 999 
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028
899 899 
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029
999 999 
$500 issued at discount to par at a price of 99.732% at 5.40%, due April 2030
499 — 
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030
503 503 
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031
997 997 
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032
676 676 
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033
1,098 1,098 
$500 issued at discount to par at a price of 99.778% at 6.10%, due April 2035
499 — 
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041
1,199 1,199 
$500 issued at par at a price of 100% at 4.75%, due March 2029
3 3 
10,043 9,044 
Other borrowings at 1.45%-7.38%, due in fiscal years 2025-2031
697 645 
Fair value adjustment related to hedged debt(6)(21)
Unamortized debt issuance cost(51)(47)
Current portion of long-term debt(1,392)(1,358)
Total long-term debt$9,291 $8,263 
(1)HP may redeem some or all of the fixed-rate U.S. Dollar Global Notes at any time in accordance with the terms thereof. The U.S. Dollar Global Notes are senior unsecured debt.
v3.25.1
Stockholders' Deficit (Tables)
 6 Months Ended
Apr. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Changes and Reclassifications Related to Other Comprehensive (Loss) Income, Net of Taxes
Changes and reclassifications related to Accumulated Other Comprehensive Loss, net of taxes
 Three months ended April 30Six months ended April 30
 2025202420252024
 In millions
Other comprehensive (loss) income, net of taxes:  
Unrealized components of available-for-sale debt securities
Balance at the beginning of period$18 $11 $14 $7 
Unrealized gains arising during the period2 — 6 4 
Unrealized components of available-for-sale debt securities, net of taxes2 — 6 4 
Balance at the end of period$20 $11 $20 $11 
Unrealized components of cash flow hedges 
Balance at the beginning of period$282 $(23)$47 $230 
Unrealized (losses) gains arising during the period
(692)151 (360)(11)
Gains reclassified into earnings(148)(5)(191)(164)
Tax effects on change in unrealized components of cash flow hedges165 (34)111 34 
Unrealized components of cash flow hedges, net of taxes(675)112 (440)(141)
Balance at the end of period$(393)$89 $(393)$89 
Unrealized components of defined benefit plans  
Balance at the beginning of period$(492)$(443)$(496)$(437)
Unrealized (losses) gains arising during the period
(2)23 (1)13 
Amortization of actuarial loss and prior service benefit(1)
5 2 10 4 
Curtailments, settlements and other1 1 — 1 
Tax effects on change in unrealized components of defined benefit plans— (6)(1)(4)
Unrealized components of defined benefit plans, net of taxes4 20 8 14 
Balance at the end of period$(488)$(423)$(488)$(423)
Cumulative translation adjustment
Balance at the beginning of period$(12)$(3)$1 $(23)
Change in cumulative translation adjustment30 (6)17 14 
Cumulative translation adjustment, net of taxes30 (6)17 14 
Balance at the end of period$18 $(9)$18 $(9)
Other comprehensive (loss) income
$(639)$126 $(409)$(109)
Accumulated other comprehensive loss$(843)$(332)$(843)$(332)
(1)These components are included in the computation of net pension and post-retirement benefit (credit) charges in Note 4, “Retirement and Post-Retirement Benefit Plans”.
v3.25.1
Earnings Per Share (Tables)
 6 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Reconciliation of the Number of Shares Used for Basic and Diluted Net EPS Calculations
A reconciliation of the number of shares used for basic and diluted net EPS calculations is as follows:
 Three months ended April 30Six months ended April 30
 2025202420252024
 In millions, except per share amounts
Numerator:  
Net earnings$406 $607 $971 $1,229 
Denominator:  
Weighted-average shares used to compute basic net EPS950 984 949 990 
Dilutive effect of employee stock plans6 6 7 6 
Weighted-average shares used to compute diluted net EPS956 990 956 996 
Net earnings per share:  
Basic$0.43 $0.62 $1.02 $1.24 
Diluted$0.42 $0.61 $1.02 $1.23 
Anti-dilutive weighted-average stock-based compensation awards(1)
10 3 7 3 
(1)HP excludes from the calculation of diluted net EPS stock options and restricted stock units where the assumed proceeds exceed the average market price, because their effect would be anti-dilutive. The assumed proceeds of a stock option include the sum of its exercise price, and average unrecognized compensation cost. The assumed proceeds of a restricted stock unit represent unrecognized compensation cost.
v3.25.1
Guarantees, Indemnifications and Warranties (Tables)
 6 Months Ended
Apr. 30, 2025
Guarantees [Abstract]  
Schedule of Aggregate Product Warranty Liabilities and Changes
HP’s aggregate product warranty liabilities and changes were as follows:
 Six months ended April 30, 2025
 In millions
Balance at beginning of period$550 
Accruals for warranties issued322 
Adjustments related to pre-existing warranties (including changes in estimates)(4)
Settlements made
(384)
Balance at end of period$484 
v3.25.1
Segment Information - Narrative (Details)
 6 Months Ended
Apr. 30, 2025
segment
Segment Reporting [Abstract]  
Number of reportable segments 3
v3.25.1
Segment Information - Schedule of Reconciliation of Segment Operating Results to HP Consolidated Results (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Net revenue:        
Total net revenue $ 13,220 $ 12,800 $ 26,724 $ 25,985
Earnings before taxes:        
Total segment earnings from operations 654 952 1,499 1,887
Restructuring and other charges (122) (71) (192) (134)
Acquisition and divestiture charges (17) (22) (23) (49)
Amortization of intangible assets (65) (80) (128) (161)
Interest and other, net (148) (155) (289) (297)
Earnings before taxes 506 797 1,210 1,590
Operating Segments        
Net revenue:        
Total net revenue 13,221 12,799 26,725 25,985
Earnings before taxes:        
Total segment earnings from operations 1,186 1,307 2,476 2,679
Other        
Net revenue:        
Total net revenue (1) 1 (1) 0
Earnings before taxes:        
Stock-based compensation expense (140) (94) (332) (271)
Restructuring and other charges (122) (71) (192) (134)
Acquisition and divestiture charges (17) (22) (23) (49)
Amortization of intangible assets (65) (80) (128) (161)
Certain litigation charges (103) 0 (103) 0
Interest and other, net (148) (155) (289) (297)
Corporate and unallocated costs and other        
Earnings before taxes:        
Corporate and unallocated costs and other (85) (88) (199) (177)
Personal Systems | Operating Segments        
Net revenue:        
Total net revenue 9,024 8,426 18,248 17,235
Earnings before taxes:        
Total segment earnings from operations 409 508 916 1,045
Printing | Operating Segments        
Net revenue:        
Total net revenue 4,181 4,368 8,450 8,743
Earnings before taxes:        
Total segment earnings from operations 814 829 1,624 1,701
Corporate Investments | Operating Segments        
Net revenue:        
Total net revenue 16 5 27 7
Earnings before taxes:        
Total segment earnings from operations (37) (30) (64) (67)
Commercial PS | Personal Systems | Operating Segments        
Net revenue:        
Total net revenue 6,786 6,242 13,431 12,287
Consumer PS | Personal Systems | Operating Segments        
Net revenue:        
Total net revenue 2,238 2,184 4,817 4,948
Supplies | Printing | Operating Segments        
Net revenue:        
Total net revenue 2,725 2,864 5,551 5,727
Commercial Printing | Printing | Operating Segments        
Net revenue:        
Total net revenue 1,167 1,205 2,311 2,432
Consumer Printing | Printing | Operating Segments        
Net revenue:        
Total net revenue $ 289 $ 299 $ 588 $ 584
v3.25.1
Restructuring and Other Charges - Schedule of Restructuring Activities by Plan (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2025
Apr. 30, 2024
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period   $ 138 $ 108
Charges $ 105 161 102
Cash payments   (118) (112)
Non-cash and other adjustments   (15) (2)
Accrued balance, end of the period 166 166 96
Total costs incurred to date 1,703 1,703  
Reflected in the Consolidated Condensed Balance Sheets      
Other current liabilities 160 160  
Other non-current liabilities 6 6  
Fiscal 2023 Plan | Severance and EER      
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period   120 88
Charges 97 141 93
Cash payments   (110) (100)
Non-cash and other adjustments   1 2
Accrued balance, end of the period 152 152 83
Total costs incurred to date 748 748  
Reflected in the Consolidated Condensed Balance Sheets      
Other current liabilities 152 152  
Other non-current liabilities 0 0  
Fiscal 2023 Plan | Non-labor      
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period   11 18
Charges 8 20 6
Cash payments   (6) (9)
Non-cash and other adjustments   (16) (2)
Accrued balance, end of the period 9 9 13
Total costs incurred to date 77 77  
Reflected in the Consolidated Condensed Balance Sheets      
Other current liabilities 3 3  
Other non-current liabilities 6 6  
Other prior-year plans      
Restructuring Reserve [Roll Forward]      
Accrued balance, beginning of the period   7 2
Charges 0 0 3
Cash payments   (2) (3)
Non-cash and other adjustments   0 (2)
Accrued balance, end of the period 5 5 $ 0
Total costs incurred to date 878 878  
Reflected in the Consolidated Condensed Balance Sheets      
Other current liabilities 5 5  
Other non-current liabilities $ 0 $ 0  
v3.25.1
Restructuring and Other Charges - Narrative (Details)
employee in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Feb. 27, 2025
USD ($)
employee
Apr. 30, 2025
USD ($)
Apr. 30, 2024
USD ($)
Apr. 30, 2025
USD ($)
Apr. 30, 2024
USD ($)
Nov. 18, 2022
USD ($)
Restructuring Cost and Reserve [Line Items]            
Other charges | $   $ 17 $ 17 $ 31 $ 32  
Fiscal 2023 Plan            
Restructuring Cost and Reserve [Line Items]            
Expected positions to be eliminated | employee 7          
Fiscal 2023 Plan | Minimum            
Restructuring Cost and Reserve [Line Items]            
Expected positions to be eliminated | employee 1          
Fiscal 2023 Plan | Maximum            
Restructuring Cost and Reserve [Line Items]            
Expected positions to be eliminated | employee 2          
Fiscal 2023 Plan | Labor and Non-Labor Actions            
Restructuring Cost and Reserve [Line Items]            
Estimated pre-tax charges | $ $ 150         $ 1,000
Fiscal 2023 Plan | Labor Costs            
Restructuring Cost and Reserve [Line Items]            
Estimated pre-tax charges | $           $ 700
v3.25.1
Retirement and Post-Retirement Benefit Plans - Schedule of Components of Pension and Post-Retirement Benefit (Credit) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Post-Retirement Benefit Plans        
Defined Benefit Plan Disclosure [Line Items]        
Service cost $ 0 $ 0 $ 0 $ 0
Interest cost 3 4 7 8
Expected return on plan assets (3) (4) (7) (8)
Amortization and deferrals:        
Actuarial loss (gain) (5) (4) (9) (8)
Prior service cost (credit) (1) (2) (3) (5)
Net periodic benefit (credit) cost (6) (6) (12) (13)
Settlement loss 0 0 0 0
Total periodic benefit (credit) cost (6) (6) (12) (13)
U.S. | Defined Benefit Plans        
Defined Benefit Plan Disclosure [Line Items]        
Service cost 0 0 0 0
Interest cost 53 57 106 114
Expected return on plan assets (62) (62) (121) (123)
Amortization and deferrals:        
Actuarial loss (gain) 8 7 15 14
Prior service cost (credit) 0 0 0 0
Net periodic benefit (credit) cost (1) 2 0 5
Settlement loss 0 0 0 0
Total periodic benefit (credit) cost (1) 2 0 5
Non-U.S. | Defined Benefit Plans        
Defined Benefit Plan Disclosure [Line Items]        
Service cost 10 9 19 18
Interest cost 10 11 20 23
Expected return on plan assets (13) (13) (27) (26)
Amortization and deferrals:        
Actuarial loss (gain) 2 0 4 0
Prior service cost (credit) 1 1 3 3
Net periodic benefit (credit) cost 10 8 19 18
Settlement loss 1 1 1 1
Total periodic benefit (credit) cost $ 11 $ 9 $ 20 $ 19
v3.25.1
Retirement and Post-Retirement Benefit Plans - Narrative (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2025
USD ($)
Post-Retirement Benefit Plans  
Defined Benefit Plan Disclosure [Line Items]  
Contributions to benefit plans $ 4
Non-U.S. | Defined Benefit Plans  
Defined Benefit Plan Disclosure [Line Items]  
Contributions to benefit plans 21
U.S. | Defined Benefit Plans  
Defined Benefit Plan Disclosure [Line Items]  
Contributions to benefit plans $ 13
v3.25.1
Taxes on Earnings (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
USD ($)
country
Apr. 30, 2024
USD ($)
Apr. 30, 2025
USD ($)
country
Apr. 30, 2024
USD ($)
Income Tax Disclosure [Abstract]        
Effective tax rate (as a percent) 19.80% 23.80% 19.80% 22.70%
Income tax reconciliation other discrete items tax charges (credits) $ (40)   $ (34)  
Effective income tax rate reconciliation, litigation charges, amount 19   19  
Restructuring benefits 24   38  
Uncertain tax position charges     15  
Changes in tax rate     17  
Excess tax benefits     15  
Unrecognized tax benefits 1,200   1,200  
Unrecognized tax benefits that would impact effective tax rate 886   886  
Unrecognized increase in tax benefits change     15  
Penalties and interest accrued 157 $ 119 $ 157 $ 119
Likelihood of no resolution period     12 months  
Reasonably possible decrease in existing unrecognized tax benefits within the next 12 months $ 182   $ 182  
Other countries with income tax jurisdiction | country 61   61  
v3.25.1
Supplementary Financial Information - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 2,697 $ 3,238    
Restricted cash 33 15    
Cash, cash equivalents and restricted cash $ 2,730 $ 3,253 $ 2,517 $ 3,232
v3.25.1
Supplementary Financial Information - Schedule of Allowance for Credit Losses Related to Accounts Receivable and Changes (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2025
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Balance at beginning of period $ 83
Current-period allowance for credit losses 6
Deductions, net of recoveries (4)
Balance at end of period $ 85
v3.25.1
Supplementary Financial Information - Schedule of Trade Receivables Sold and Cash Received (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Trade Receivables Sold and Cash Received [Roll Forward]        
Balance at beginning of period $ 133 $ 212 $ 284 $ 141
Trade receivables sold 3,125 2,846 6,174 6,145
Cash receipts (3,056) (2,873) (6,247) (6,106)
Foreign currency and other 15 (4) 6 1
Balance at end of period $ 217 $ 181 $ 217 $ 181
v3.25.1
Supplementary Financial Information - Schedule of Inventory (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finished goods $ 4,469 $ 4,338
Purchased parts and fabricated assemblies 3,706 3,382
Inventory $ 8,175 $ 7,720
v3.25.1
Supplementary Financial Information - Schedule of Other Current Assets (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Supplier and other receivables $ 1,404 $ 2,180
Prepaid and other current assets 1,840 1,462
Value-added taxes receivable 973 1,028
Other current assets $ 4,217 $ 4,670
v3.25.1
Supplementary Financial Information - Schedule of Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Property, Plant and Equipment, Net    
Property, plant and equipment, gross $ 8,306 $ 7,992
Accumulated depreciation (5,355) (5,078)
Property, plant and equipment, net 2,951 2,914
Land, buildings and leasehold improvements    
Property, Plant and Equipment, Net    
Property, plant and equipment, gross 2,560 2,527
Machinery and equipment, including equipment held for lease    
Property, Plant and Equipment, Net    
Property, plant and equipment, gross $ 5,746 $ 5,465
v3.25.1
Supplementary Financial Information - Schedule of Other Non-Current Assets (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred tax assets $ 3,513 $ 3,311
Intangible assets $ 1,228 $ 1,319
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Right-of-use assets $ 1,104 $ 1,165
Prepaid pension and post-retirement benefit assets 389 362
Deposits and prepaid 305 322
Other 1,138 1,129
Other non-current assets $ 7,677 $ 7,608
v3.25.1
Supplementary Financial Information - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Sales and marketing programs $ 2,826 $ 3,060
Deferred revenue 1,495 1,446
Other accrued taxes 1,141 1,233
Employee compensation and benefits 743 970
Warranty $ 429 $ 486
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other accrued liabilities Other accrued liabilities
Operating lease liabilities $ 413 $ 443
Tax liability 263 291
Other 2,605 2,449
Other accrued liabilities $ 9,915 $ 10,378
v3.25.1
Supplementary Financial Information - Schedule of Other Non-Current Liabilities (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred revenue $ 1,544 $ 1,487
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
Operating lease liabilities $ 766 $ 787
Tax liability 755 839
Pension, post-retirement, and post-employment liabilities 597 607
Deferred tax liability 29 31
Other 537 531
Other non-current liabilities $ 4,228 $ 4,282
v3.25.1
Supplementary Financial Information - Schedule of Interest and Other, Net (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Interest expense on borrowings $ (114) $ (122) $ (218) $ (238)
Factoring costs (32) (40) (69) (79)
Non-operating retirement-related credits 4 2 10 6
Other, net (6) 5 (12) 14
Interest and other, net $ (148) $ (155) $ (289) $ (297)
v3.25.1
Supplementary Financial Information - Schedule of Net Revenue by Region (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Disaggregation of Revenue [Line Items]        
Total net revenue $ 13,220 $ 12,800 $ 26,724 $ 25,985
Americas        
Disaggregation of Revenue [Line Items]        
Total net revenue 5,793 5,591 11,312 10,999
Europe, Middle East and Africa        
Disaggregation of Revenue [Line Items]        
Total net revenue 4,393 4,373 9,147 9,041
Asia-Pacific and Japan        
Disaggregation of Revenue [Line Items]        
Total net revenue $ 3,034 $ 2,836 $ 6,265 $ 5,945
v3.25.1
Supplementary Financial Information - Value of Remaining Performance Obligations (Narrative) (Details)
$ in Billions
Apr. 30, 2025
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 4.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-05-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 1.8
Remaining performance obligations period 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-05-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligations $ 2.2
Remaining performance obligations period
v3.25.1
Supplementary Financial Information - Contract Liabilities (Narrative) (Details) - USD ($)
$ in Billions
 6 Months Ended
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Contract liability $ 3.0 $ 2.9
Revenue recognized $ 0.9  
v3.25.1
Supplementary Financial Information - Supplier Finance Programs (Narrative) (Details) - USD ($)
$ in Billions
Apr. 30, 2025
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Payment terms offered by HP 30 days  
Obligations outstanding $ 7.7 $ 7.8
Amounts owed to participating financial institutions $ 0.6 $ 0.9
v3.25.1
Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Assets:    
Cash Equivalents: $ 1,958 $ 2,344
Derivative Instruments: 66 229
Liabilities:    
Derivative Instruments: 571 182
Fair Value Measured on a Recurring Basis    
Assets:    
Total assets 2,203 2,760
Liabilities:    
Total liabilities 571 182
Fair Value Measured on a Recurring Basis | Time deposits    
Assets:    
Cash Equivalents: 1,237 1,012
Fair Value Measured on a Recurring Basis | Government debt    
Assets:    
Cash Equivalents: 721 1,332
Fair Value Measured on a Recurring Basis | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 3 3
Fair Value Measured on a Recurring Basis | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 176 184
Liabilities:    
Debt securities, restricted 69 78
Fair Value Measured on a Recurring Basis | Interest rate contracts    
Assets:    
Derivative Instruments: 0 4
Liabilities:    
Derivative Instruments: 6 22
Fair Value Measured on a Recurring Basis | Foreign currency contracts    
Assets:    
Derivative Instruments: 63 225
Liabilities:    
Derivative Instruments: 565 158
Fair Value Measured on a Recurring Basis | Other derivatives    
Assets:    
Derivative Instruments: 3 0
Liabilities:    
Derivative Instruments: 0 2
Fair Value Measured on a Recurring Basis | Level 1    
Assets:    
Total assets 774 1,386
Liabilities:    
Total liabilities 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Time deposits    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Government debt    
Assets:    
Cash Equivalents: 721 1,332
Fair Value Measured on a Recurring Basis | Level 1 | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 53 54
Fair Value Measured on a Recurring Basis | Level 1 | Interest rate contracts    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Foreign currency contracts    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 1 | Other derivatives    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 2    
Assets:    
Total assets 1,429 1,374
Liabilities:    
Total liabilities 571 182
Fair Value Measured on a Recurring Basis | Level 2 | Time deposits    
Assets:    
Cash Equivalents: 1,237 1,012
Fair Value Measured on a Recurring Basis | Level 2 | Government debt    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 2 | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 3 3
Fair Value Measured on a Recurring Basis | Level 2 | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 123 130
Fair Value Measured on a Recurring Basis | Level 2 | Interest rate contracts    
Assets:    
Derivative Instruments: 0 4
Liabilities:    
Derivative Instruments: 6 22
Fair Value Measured on a Recurring Basis | Level 2 | Foreign currency contracts    
Assets:    
Derivative Instruments: 63 225
Liabilities:    
Derivative Instruments: 565 158
Fair Value Measured on a Recurring Basis | Level 2 | Other derivatives    
Assets:    
Derivative Instruments: 3 0
Liabilities:    
Derivative Instruments: 0 2
Fair Value Measured on a Recurring Basis | Level 3    
Assets:    
Total assets 0 0
Liabilities:    
Total liabilities 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Time deposits    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Government debt    
Assets:    
Cash Equivalents: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Financial institution instruments    
Assets:    
Available-for-Sale Investments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Marketable securities and mutual funds    
Assets:    
Available-for-Sale Investments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Interest rate contracts    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Foreign currency contracts    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: 0 0
Fair Value Measured on a Recurring Basis | Level 3 | Other derivatives    
Assets:    
Derivative Instruments: 0 0
Liabilities:    
Derivative Instruments: $ 0 $ 0
v3.25.1
Fair Value - Narrative (Details) - USD ($)
$ in Billions
Apr. 30, 2025
Oct. 31, 2024
Fair Value Disclosures [Abstract]    
Fair value, short- and long-term debt $ 10.4 $ 9.4
Carrying value, short- and long-term debt $ 10.7 $ 9.7
v3.25.1
Financial Instruments - Schedule of Cash Equivalents and Available-for-Sale Investments (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Cash Equivalents:    
Cost $ 1,958 $ 2,344
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,958 2,344
Available-for-Sale Investments:    
Cost 115 118
Gross Unrealized Gain 64 69
Gross Unrealized Loss 0 0
Fair Value 179 187
Total cash equivalents and available-for-sale investments, cost 2,073 2,462
Total cash equivalents and available-for-sale investments, gross unrealized gain 64 69
Total cash equivalents and available-for-sale investments, gross unrealized loss 0 0
Total cash equivalents and available-for-sale investments, fair value 2,137 2,531
Time deposits    
Cash Equivalents:    
Cost 1,237 1,012
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 1,237 1,012
Government debt    
Cash Equivalents:    
Cost 721 1,332
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 721 1,332
Financial institution instruments    
Available-for-Sale Investments:    
Debt securities, cost 3 3
Debt securities, gross unrealized gain 0 0
Debt securities, gross unrealized loss 0 0
Debt securities, fair value 3 3
Marketable securities and mutual funds    
Available-for-Sale Investments:    
Equity securities, cost 112 115
Equity securities, gross unrealized gain 64 69
Equity securities, gross unrealized loss 0 0
Equity securities, fair value 176 184
Marketable securities and mutual funds | Fair Value Measured on a Recurring Basis    
Available-for-Sale Investments:    
Debt securities, restricted $ 69 $ 78
v3.25.1
Financial Instruments - Schedule of Contractual Maturities of Investments in Available-for-Sale Debt Securities (Details)
$ in Millions
Apr. 30, 2025
USD ($)
Amortized Cost  
Due in one year $ 17
Due in one to five years 55
Amortized Cost 72
Fair Value  
Due in one year 17
Due in one to five years 55
Fair Value $ 72
v3.25.1
Financial Instruments - Narrative (Details) - USD ($)
 1 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2025
Oct. 31, 2024
Derivatives, Fair Value      
Fair value of derivatives with credit contingent features in a net liability position $ 506,000,000 $ 506,000,000 $ 59,000,000
Period to collateralize   2 days  
Notional amount 20,910,000,000 $ 20,910,000,000 20,253,000,000
Gain expected to be reclassified from AOCI into earnings in next 12 months   351,000,000  
Forward Contracts      
Derivatives, Fair Value      
Notional amount 825,000,000 $ 825,000,000  
Other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification and tax, parent 6,000,000    
Cash flow hedges:      
Derivatives, Fair Value      
Foreign currency maturity   12 months  
Other Non-Current Assets      
Derivatives, Fair Value      
Cost method and other equity investments $ 100,000,000 $ 100,000,000 $ 107,000,000
v3.25.1
Financial Instruments - Schedule of Gross Notional and Fair Value of Derivative Financial Instruments in the Consolidated Condensed Balance Sheets (Details) - USD ($)
Apr. 30, 2025
Oct. 31, 2024
Derivatives, Fair Value    
Outstanding Gross Notional $ 20,910,000,000 $ 20,253,000,000
Derivative instruments, assets 66,000,000 229,000,000
Derivative instruments, liabilities $ 571,000,000 $ 182,000,000
Other Current Assets    
Derivatives, Fair Value    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets
Derivative instruments, assets $ 57,000,000 $ 189,000,000
Other Non-Current Assets    
Derivatives, Fair Value    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Derivative instruments, assets $ 9,000,000 $ 40,000,000
Other Current Liabilities    
Derivatives, Fair Value    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Derivative instruments, liabilities $ 480,000,000 $ 137,000,000
Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other non-current liabilities Other non-current liabilities
Derivative instruments, liabilities $ 91,000,000 $ 45,000,000
Forward Contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 825,000,000  
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 750,000,000 750,000,000
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 6,000,000 11,000,000
Derivatives designated as hedging instruments | Fair value hedges: | Interest rate contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 10,000,000
Derivatives designated as hedging instruments | Cash flow hedges:    
Derivatives, Fair Value    
Outstanding Gross Notional 16,193,000,000 15,813,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 40,000,000 169,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 9,000,000 40,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 462,000,000 128,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 91,000,000 45,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Interest rate contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 0 500,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Interest rate contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives designated as hedging instruments | Cash flow hedges: | Interest rate contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 4,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Interest rate contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives designated as hedging instruments | Cash flow hedges: | Interest rate contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 1,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 15,443,000,000 14,563,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 40,000,000 169,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 9,000,000 36,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 456,000,000 117,000,000
Derivatives designated as hedging instruments | Cash flow hedges: | Foreign currency contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 91,000,000 34,000,000
Derivatives not designated as hedging instruments    
Derivatives, Fair Value    
Outstanding Gross Notional 4,717,000,000 4,440,000,000
Derivatives not designated as hedging instruments | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 17,000,000 20,000,000
Derivatives not designated as hedging instruments | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 18,000,000 9,000,000
Derivatives not designated as hedging instruments | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives not designated as hedging instruments | Foreign currency contracts    
Derivatives, Fair Value    
Outstanding Gross Notional 4,571,000,000 4,284,000,000
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 14,000,000 20,000,000
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 18,000,000 7,000,000
Derivatives not designated as hedging instruments | Foreign currency contracts | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 0
Derivatives not designated as hedging instruments | Other derivatives    
Derivatives, Fair Value    
Outstanding Gross Notional 146,000,000 156,000,000
Derivatives not designated as hedging instruments | Other derivatives | Other Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 3,000,000 0
Derivatives not designated as hedging instruments | Other derivatives | Other Non-Current Assets    
Derivatives, Fair Value    
Derivative instruments, assets 0 0
Derivatives not designated as hedging instruments | Other derivatives | Other Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities 0 2,000,000
Derivatives not designated as hedging instruments | Other derivatives | Other Non-Current Liabilities    
Derivatives, Fair Value    
Derivative instruments, liabilities $ 0 $ 0
v3.25.1
Financial Instruments - Schedule of Information Related to the Potential Effect of Entity's Master Netting Agreements and Collateral Security Agreements (Details) - USD ($)
$ in Millions
 6 Months Ended
Apr. 30, 2025
Oct. 31, 2024
Derivative assets    
Gross Amount Recognized $ 66 $ 229
Gross Amount Offset 0 0
Net Amount Presented 66 229
Gross Amounts Not Offset    
Derivatives 59 113
Financial Collateral 0 88
Net Amount 7 28
Derivative liabilities    
Gross Amount Recognized 571 182
Gross Amount Offset 0 0
Net Amount Presented 571 182
Gross Amounts Not Offset    
Derivatives 59 113
Financial Collateral 535 61
Net Amount $ (23) $ 8
Period to collateralize 2 days  
v3.25.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments and Related Hedged Items in a Fair Value Hedging Relationship (Details) - Interest rate contracts - Interest and other, net - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Derivative Instruments, Gain (Loss) [Line Items]        
Total amounts of income/(expense) line items in the statement of financial performance in which the effects of fair value hedges are recorded $ (148) $ (155) $ (289) $ (297)
Gain/(loss) recognized in earnings on derivative instruments 8 0 15 15
Gain/(loss) recognized in earnings on hedged item $ (8) $ 0 $ (15) $ (15)
v3.25.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized (losses) gains arising during the period $ (692) $ 151 $ (360) $ (11)
Cash flow hedges:        
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized (losses) gains arising during the period (692) 151 (360) (11)
Foreign currency contracts | Cash flow hedges:        
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized (losses) gains arising during the period (687) 151 (363) (11)
Interest rate contracts | Cash flow hedges:        
Derivative Instruments, Gain (Loss) [Line Items]        
Unrealized (losses) gains arising during the period $ (5) $ 0 $ 3 $ 0
v3.25.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments in Cash Flow Hedging Relationships Included in Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Pre-tax effect of derivative instruments in cash flow hedging relationships        
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings $ 148 $ 5 $ 191 $ 164
Cash flow hedges:        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings 148 5 191 164
Cash flow hedges: | Products net revenue        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings 167 39 234 238
Cash flow hedges: | Cost of products net revenue        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings (23) (36) (50) (76)
Cash flow hedges: | Operating expenses        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings 1 (1) 1 (4)
Cash flow hedges: | Interest and other, net        
Pre-tax effect of derivative instruments in cash flow hedging relationships        
Gain/(loss) reclassified from Accumulated  other comprehensive (loss) income into earnings $ 3 $ 3 $ 6 $ 6
v3.25.1
Financial Instruments - Schedule of Pre-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments Recognized in Interest and Other, Net in the Consolidated Condensed Statements of Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instrument $ (10) $ 0 $ (9) $ 5
Interest and other, net | Foreign currency contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instrument (11) 6 (14) 7
Interest and other, net | Other derivatives        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain/(loss) recognized in earnings on derivative instrument $ 1 $ (6) $ 5 $ (2)
v3.25.1
Borrowings - Schedule of Notes Payable and Short-Term Borrowings (Details) - USD ($)
$ in Millions
Apr. 30, 2025
Oct. 31, 2024
Amount Outstanding    
Current portion of long-term debt $ 1,392 $ 1,358
Notes payable to banks, lines of credit and other $ 1,446 $ 1,406
Weighted-Average Interest Rate    
Current portion of long-term debt 4.90% 5.00%
Notes payable to banks, lines of credit and other    
Amount Outstanding    
Notes payable to banks, lines of credit and other $ 54 $ 48
Weighted-Average Interest Rate    
Notes payable to banks, lines of credit and other 0.00% 0.00%
v3.25.1
Borrowings - Schedule of Long-Term Debt (Details) - USD ($)
Apr. 30, 2025
Oct. 31, 2024
Long-term debt    
Fair value adjustment related to hedged debt $ (6,000,000) $ (21,000,000)
Unamortized debt issuance cost (51,000,000) (47,000,000)
Current portion of long-term debt (1,392,000,000) (1,358,000,000)
Total long-term debt 9,291,000,000 8,263,000,000
U.S. Dollar Global Notes    
Long-term debt    
Long-term debt 10,043,000,000 9,044,000,000
$1,150 issued at discount to par at a price of 99.769% at 2.20%, due June 2025    
Long-term debt    
Face amount of debt instrument $ 1,150,000,000  
Discount to par (percent) 99.769%  
Interest rate (percent) 2.20%  
Long-term debt $ 1,150,000,000 1,150,000,000
$1,000 issued at discount to par at a price of 99.808% at 1.45%, due June 2026    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.808%  
Interest rate (percent) 1.45%  
Long-term debt $ 522,000,000 521,000,000
$1,000 issued at discount to par at a price of 99.718% at 3.00%, due June 2027    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.718%  
Interest rate (percent) 3.00%  
Long-term debt $ 999,000,000 999,000,000
$900 issued at discount to par at a price of 99.841% at 4.75%, due January 2028    
Long-term debt    
Face amount of debt instrument $ 900,000,000  
Discount to par (percent) 99.841%  
Interest rate (percent) 4.75%  
Long-term debt $ 899,000,000 899,000,000
$1,000 issued at discount to par at a price of 99.767% at 4.00%, due April 2029    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.767%  
Interest rate (percent) 4.00%  
Long-term debt $ 999,000,000 999,000,000
$500 issued at discount to par at a price of 99.732% at 5.40%, due April 2030    
Long-term debt    
Face amount of debt instrument $ 500,000,000  
Discount to par (percent) 99.732%  
Interest rate (percent) 5.40%  
Long-term debt $ 499,000,000 0
$850 issued at discount to par at a price of 99.790% at 3.40%, due June 2030    
Long-term debt    
Face amount of debt instrument $ 850,000,000  
Discount to par (percent) 99.79%  
Interest rate (percent) 3.40%  
Long-term debt $ 503,000,000 503,000,000
$1,000 issued at discount to par at a price of 99.573% at 2.65%, due June 2031    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.573%  
Interest rate (percent) 2.65%  
Long-term debt $ 997,000,000 997,000,000
$1,000 issued at discount to par at a price of 99.966% at 4.20%, due April 2032    
Long-term debt    
Face amount of debt instrument $ 1,000,000,000  
Discount to par (percent) 99.966%  
Interest rate (percent) 4.20%  
Long-term debt $ 676,000,000 676,000,000
$1,100 issued at discount to par at a price of 99.725% at 5.50%, due January 2033    
Long-term debt    
Face amount of debt instrument $ 1,100,000,000  
Discount to par (percent) 99.725%  
Interest rate (percent) 5.50%  
Long-term debt $ 1,098,000,000 1,098,000,000
$500 issued at discount to par at a price of 99.778% at 6.10%, due April 2035    
Long-term debt    
Face amount of debt instrument $ 500,000,000  
Discount to par (percent) 99.778%  
Interest rate (percent) 6.10%  
Long-term debt $ 499,000,000 0
$1,200 issued at discount to par at a price of 99.863% at 6.00%, due September 2041    
Long-term debt    
Face amount of debt instrument $ 1,200,000,000  
Discount to par (percent) 99.863%  
Interest rate (percent) 6.00%  
Long-term debt $ 1,199,000,000 1,199,000,000
$500 issued at par at a price of 100% at 4.75%, due March 2029    
Long-term debt    
Face amount of debt instrument $ 500,000,000  
Issuance rate (percent) 100.00%  
Interest rate (percent) 4.75%  
Long-term debt $ 3,000,000 3,000,000
Other borrowings at 1.45%-7.38%, due in fiscal years 2025-2031    
Long-term debt    
Other borrowings at 1.45%-7.38%, due in fiscal years 2025-2031 $ 697,000,000 $ 645,000,000
Other borrowings at 1.45%-7.38%, due in fiscal years 2025-2031 | Minimum    
Long-term debt    
Interest rate (percent) 1.45%  
Other borrowings at 1.45%-7.38%, due in fiscal years 2025-2031 | Maximum    
Long-term debt    
Interest rate (percent) 7.38%  
v3.25.1
Borrowings - Narrative (Details) - USD ($)
 1 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2025
Oct. 31, 2024
Line of Credit Facility [Line Items]      
Outstanding Gross Notional $ 20,910,000,000 $ 20,910,000,000 $ 20,253,000,000
Commercial Paper      
Line of Credit Facility [Line Items]      
Maximum borrowing capacity under credit facility 6,000,000,000 6,000,000,000  
Revolving Credit Facility      
Line of Credit Facility [Line Items]      
Maximum borrowing capacity under credit facility 5,000,000,000 5,000,000,000  
Credit Facilities      
Line of Credit Facility [Line Items]      
Available borrowing resources 1,100,000,000 1,100,000,000  
Forward Contracts      
Line of Credit Facility [Line Items]      
Outstanding Gross Notional 825,000,000 825,000,000  
U.S. Dollar Global Notes , Due April 2030 And 2035 | Senior Notes      
Line of Credit Facility [Line Items]      
Face amount of debt instrument 1,000,000,000 1,000,000,000  
U.S. Dollar Global Notes , Due April 2030      
Line of Credit Facility [Line Items]      
Face amount of debt instrument $ 500,000,000 $ 500,000,000  
Interest rate (percent) 5.40% 5.40%  
U.S. Dollar Global Notes , Due April 2030 | Senior Notes      
Line of Credit Facility [Line Items]      
Face amount of debt instrument $ 500,000,000 $ 500,000,000  
Interest rate (percent) 5.40% 5.40%  
U.S. Dollar Global Notes , Due April 2035      
Line of Credit Facility [Line Items]      
Face amount of debt instrument $ 500,000,000 $ 500,000,000  
Interest rate (percent) 6.10% 6.10%  
U.S. Dollar Global Notes , Due April 2035 | Senior Notes      
Line of Credit Facility [Line Items]      
Face amount of debt instrument $ 500,000,000 $ 500,000,000  
Interest rate (percent) 6.10% 6.10%  
U.S. Dollar Global Notes , Due April And Oct 2025 | Senior Notes      
Line of Credit Facility [Line Items]      
Issuance costs $ 9,000,000    
New Revolving Facility | Revolving Credit Facility      
Line of Credit Facility [Line Items]      
Revolving credit facility, term   5 years  
v3.25.1
Stockholders' Deficit - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Stockholders' Equity Note [Abstract]        
Repurchases of common stock (in shares) 3.1 3.5 5.8 20.5
Payment in connection with repurchases of shares $ 100 $ 100 $ 200 $ 600
Shares settled (in shares) 0.3 0.3 0.3 0.3
Share repurchase authorization remaining $ 9,100   $ 9,100  
v3.25.1
Stockholders' Deficit - Schedule of Taxes Related to Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Jan. 31, 2025
Apr. 30, 2024
Jan. 31, 2024
Apr. 30, 2025
Apr. 30, 2024
Components of accumulated other comprehensive income, net of taxes            
Balance at the beginning of period $ (1,072) $ (1,323) $ (1,640) $ (1,069) $ (1,323) $ (1,069)
Tax effects on change in unrealized components 165   (40)   110 30
Other comprehensive (loss) income, net of taxes (639) 230 126 (235) (409) (109)
Balance at the end of period (1,276) (1,072) (916) (1,640) (1,276) (916)
Unrealized components of available-for-sale debt securities            
Components of accumulated other comprehensive income, net of taxes            
Balance at the beginning of period 18 14 11 7 14 7
Unrealized (losses) gains arising during the period 2   0   6 4
Other comprehensive (loss) income, net of taxes 2   0   6 4
Balance at the end of period 20 18 11 11 20 11
Unrealized components of cash flow hedges            
Components of accumulated other comprehensive income, net of taxes            
Balance at the beginning of period 282 47 (23) 230 47 230
Unrealized (losses) gains arising during the period (692)   151   (360) (11)
Gains reclassified into earnings (148)   (5)   (191) (164)
Tax effects on change in unrealized components 165   (34)   111 34
Other comprehensive (loss) income, net of taxes (675)   112   (440) (141)
Balance at the end of period (393) 282 89 (23) (393) 89
Unrealized components of defined benefit plans            
Components of accumulated other comprehensive income, net of taxes            
Balance at the beginning of period (492) (496) (443) (437) (496) (437)
Unrealized (losses) gains arising during the period (2)   23   (1) 13
Tax effects on change in unrealized components 0   (6)   (1) (4)
Other comprehensive (loss) income, net of taxes 4   20   8 14
Balance at the end of period (488) (492) (423) (443) (488) (423)
Amortization of actuarial loss and prior service benefit            
Components of accumulated other comprehensive income, net of taxes            
Gains reclassified into earnings 5   2   10 4
Curtailments, settlements and other            
Components of accumulated other comprehensive income, net of taxes            
Gains reclassified into earnings 1   1   0 1
Cumulative translation adjustment            
Components of accumulated other comprehensive income, net of taxes            
Balance at the beginning of period (12) 1 (3) (23) 1 (23)
Unrealized (losses) gains arising during the period 30   (6)   17 14
Other comprehensive (loss) income, net of taxes 30   (6)   17 14
Balance at the end of period 18 (12) (9) (3) 18 (9)
Accumulated other comprehensive loss            
Components of accumulated other comprehensive income, net of taxes            
Balance at the beginning of period (204) (434) (458) (223) (434) (223)
Other comprehensive (loss) income, net of taxes (639) 230 126 (235)    
Balance at the end of period $ (843) $ (204) $ (332) $ (458) $ (843) $ (332)
v3.25.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Apr. 30, 2025
Apr. 30, 2024
Numerator:        
Net earnings, basic $ 406 $ 607 $ 971 $ 1,229
Net earnings, diluted $ 406 $ 607 $ 971 $ 1,229
Denominator:        
Weighted-average shares used to compute basic net EPS (in shares) 950 984 949 990
Dilutive effect of employee stock plans (in shares) 6 6 7 6
Weighted-average shares used to compute diluted net EPS (in shares) 956 990 956 996
Net earnings per share:        
Basic (usd per share) $ 0.43 $ 0.62 $ 1.02 $ 1.24
Diluted (usd per share) $ 0.42 $ 0.61 $ 1.02 $ 1.23
Anti-dilutive weighted-average stock-based compensation awards (in shares) 10 3 7 3
v3.25.1
Litigation and Contingencies (Details)
$ in Millions
 1 Months Ended 6 Months Ended 12 Months Ended 17 Months Ended
Jan. 24, 2013
USD ($)
Dec. 11, 2012
USD ($)
Apr. 21, 2012
USD ($)
May 10, 2010
USD ($)
employee
Feb. 29, 2024
USD ($)
Jan. 31, 2024
claim
Oct. 31, 2020
patent
Sep. 30, 2020
patent
Apr. 30, 2025
patent
Dec. 31, 2015
employee
subsidiary
Apr. 30, 2022
claim
Apr. 20, 2012
USD ($)
Apr. 11, 2012
USD ($)
Litigation and Contingencies                          
Aggregate damages sought         $ 4,000                
Philips Patent Litigation                          
Litigation and Contingencies                          
Patents allegedly infringed | patent               4          
Patents withdrawn | patent             2            
Dynamic Security Litigation                          
Litigation and Contingencies                          
New claims filed | claim           1         2    
Wilus                          
Litigation and Contingencies                          
Patents allegedly infringed | patent                 3        
India Directorate of Revenue Intelligence Proceedings                          
Litigation and Contingencies                          
Number of current employees | employee       7                  
Number of former employee | employee       1                  
Aggregate damages sought       $ 370                  
Loss contingency deposit to prevent interruption of business       $ 16                  
Duties and penalties under show cause notices                       $ 17 $ 386
Amount deposited under show cause notice prior to order                       $ 7 $ 9
Additional amount deposited against products-related show cause notice   $ 10                      
Additional amount deposited against parts-related show cause notice     $ 3                    
Additional amount deposited against product order $ 24                        
Autonomy-Related Legal Matters | Autonomy                          
Litigation and Contingencies                          
Number of subsidiaries | subsidiary                   4      
Number of members | employee                   2      
v3.25.1
Guarantees, Indemnifications and Warranties (Details)
$ in Millions
 6 Months Ended
Apr. 30, 2025
USD ($)
Changes in aggregated product warranty liabilities  
Balance at beginning of period $ 550
Accruals for warranties issued 322
Adjustments related to pre-existing warranties (including changes in estimates) (4)
Settlements made (384)
Balance at end of period $ 484